Newsletter
FDA Calendar
Market Data
Heat Map
Screener
Insider Trades
LOGIN
|
REGISTER
Index
Newsroom
Featured Stocks
Free Daily Newsletter
Stock Lists
See All Health Stock Lists
Biotechnology Stocks
Pharmaceutical Stocks
Big Pharma Stocks
Healthcare Stocks
Medical Stocks
Diagnostics & Research Stocks
Medical Device Stocks
Biotechnology News
Pharmaceutical News
Medical News
Healthcare News
Register
FDA Calendar
Market Data
Stock Screener
Insider Trades
Search
Logout
Index
Newsroom
Featured Stocks
Stock Lists
Biotech
Pharma
Medical
Healthcare
Watch List
Recent Insider Transactions
Filter
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ
ME
23andMe
HIBBS KATHY L
/
officer: Chief Administrative Officer
03/21/2024
Sell
$0.46
38,548
$18K
1.25M
NASDAQ
TSVT
2seventy bio
Casdin Capital, LLC
/
director
03/22/2024
Buy
$5.12
147,377
$754K
1.63M
NASDAQ
TSVT
2seventy bio
Casdin Capital, LLC
/
director
03/25/2024
Buy
$5.07
330,000
$1.674M
1.96M
NASDAQ
TSVT
2seventy bio
Casdin Capital, LLC
/
director
03/21/2024
Buy
$4.90
300,000
$1.471M
1.48M
NASDAQ
FDMT
4D Molecular Therapeutics
Bizily Scott
/
officer: Chief Legal Officer
03/18/2024
Sell
$31.27
1,750
$55K
1,737
NYSE
ABBV
AbbVie
Stewart Jeffrey Ryan
/
officer: EVP, CHIEF COMMERCIAL OFFICER
03/18/2024
Sell
$179.03
5,099
$913K
88,681
NYSE
ABBV
AbbVie
Donoghoe Nicholas
/
officer: EVP, CHIEF BUS/STRAT OFFICER
03/20/2024
Sell
$176.30
21,082
$3.717M
55,903
NYSE
ABBV
AbbVie
Stewart Jeffrey Ryan
/
officer: EVP, CHIEF COMMERCIAL OFFICER
03/18/2024
Sell
$178.85
26,110
$4.670M
93,780
NYSE
ABBV
AbbVie
Stewart Jeffrey Ryan
/
officer: EVP, CHIEF COMMERCIAL OFFICER
03/18/2024
Sell
$178.69
27,740
$4.957M
60,941
NASDAQ
ACAD
Acadia Pharmaceuticals
Schneyer Mark C.
/
officer: EVP, CHIEF FINANCIAL OFFICER
03/27/2024
Sell
$17.90
5,434
$97K
26,183
NASDAQ
ACAD
Acadia Pharmaceuticals
DAVIS STEPHEN
/
director, officer: CEO
03/27/2024
Sell
$17.90
17,714
$317K
118,842
NASDAQ
ACAD
Acadia Pharmaceuticals
Teehan Brendan
/
officer: EVP, COO, HEAD OF COMMERCIAL
03/27/2024
Sell
$17.90
5,140
$92K
36,340
NASDAQ
ACCD
Accolade
Barnes Stephen H.
/
officer: Chief Financial Officer
03/19/2024
Sell
$9.48
119
$1K
177,706
NASDAQ
ACCD
Accolade
SINGH RAJEEV
/
director, officer: Chief Executive Officer
03/19/2024
Sell
$9.48
376
$4K
745,748
NASDAQ
ACCD
Accolade
Cavanaugh Robert N
/
officer: President
03/19/2024
Sell
$9.48
181
$2K
171,640
NASDAQ
ADMA
ADMA Biologics
ELMS STEVE
/
director
03/15/2024
Sell
$6.01
183,008
$1.100M
2.58M
NASDAQ
ADMA
ADMA Biologics
ELMS STEVE
/
director
03/14/2024
Sell
$6.05
448,276
$2.712M
2.76M
NASDAQ
ADMA
ADMA Biologics
ELMS STEVE
/
director
03/19/2024
Sell
$6.08
411,829
$2.504M
2.12M
NASDAQ
ADMA
ADMA Biologics
ELMS STEVE
/
director
03/13/2024
Sell
$6.21
407,000
$2.527M
3.21M
NASDAQ
ADMA
ADMA Biologics
ELMS STEVE
/
director
03/18/2024
Sell
$6.01
49,887
$300K
2.53M
NASDAQ
AVTE
Aerovate Therapeutics
Gillies Hunter
/
officer: CHIEF MEDICAL OFFICER
03/18/2024
Sell
$26.40
613
$16K
3,251
NASDAQ
AVTE
Aerovate Therapeutics
Dake Benjamin T
/
officer: SEE REMARKS
03/25/2024
Sell
$28.01
3,432
$96K
1,291
NASDAQ
AVTE
Aerovate Therapeutics
Gillies Hunter
/
officer: CHIEF MEDICAL OFFICER
03/18/2024
Sell
$25.81
6,387
$165K
3,864
NASDAQ
AVTE
Aerovate Therapeutics
Verwijs Marinus
/
officer: CHIEF TECHNICAL OFFICER
03/19/2024
Sell
$26.46
2,764
$73K
0
NASDAQ
AVTE
Aerovate Therapeutics
Verwijs Marinus
/
officer: CHIEF TECHNICAL OFFICER
03/19/2024
Sell
$25.68
2,536
$65K
2,764
NASDAQ
AVTE
Aerovate Therapeutics
Dake Benjamin T
/
officer: SEE REMARKS
03/18/2024
Sell
$26.48
7,581
$201K
1,291
NASDAQ
AVTE
Aerovate Therapeutics
Dake Benjamin T
/
officer: SEE REMARKS
03/18/2024
Sell
$25.74
27,476
$707K
8,872
NYSE
A
Agilent Technologies
Binns Philip
/
officer: Senior Vice President
03/25/2024
Sell
$147.54
2,827
$417K
9,997
NYSE
AGTI
Agiliti
Neumann Lee M
/
officer: EVP & GC
03/20/2024
Sell
$10.07
4,685
$47K
34,614
NYSEAMEX
AIM
AIM ImmunoTech
BRYAN NANCY
/
director
03/21/2024
Buy
$0.39
38,462
$15K
38,462
NYSEAMEX
AIM
AIM ImmunoTech
Rodino Peter W III
/
officer: COO, Secretary, Gen. Counsel
03/15/2024
Buy
$0.33
37,879
$13K
181,718
NYSEAMEX
AIM
AIM ImmunoTech
Equels Thomas K
/
director, officer: CEO & President
03/15/2024
Buy
$0.33
75,758
$25K
716,455
NYSEAMEX
AIM
AIM ImmunoTech
APPELROUTH STEWART
/
director
03/15/2024
Buy
$0.33
90,910
$30K
239,765
NASDAQ
AKYA
Akoya Biosciences
McKelligon Brian
/
director, officer: President and CEO
03/20/2024
Sell
$4.97
7,500
$37K
231,868
NASDAQ
AKYA
Akoya Biosciences
McKelligon Brian
/
director, officer: President and CEO
03/13/2024
Sell
$4.94
7,500
$37K
224,368
NASDAQ
AKYA
Akoya Biosciences
McKelligon Brian
/
director, officer: President and CEO
03/13/2024
Sell
$4.94
7,500
$37K
231,868
NASDAQ
ALHC
Alignment Health
Maroney Dawn Christine
/
officer: President, Markets
03/15/2024
Sell
$4.89
21,537
$105K
2.02M
NASDAQ
ALHC
Alignment Health
Maroney Dawn Christine
/
officer: President, Markets
03/20/2024
Sell
$4.83
13,252
$64K
1.99M
NASDAQ
ALHC
Alignment Health
KAO JOHN E
/
director, officer: Chief Executive Officer
03/14/2024
Buy
$4.82
103,000
$497K
2.75M
NASDAQ
ALHC
Alignment Health
Freeman Robert Thomas
/
officer: Chief Financial Officer
03/19/2024
Sell
$5.05
28,522
$144K
869,706
NASDAQ
ALHC
Alignment Health
Maroney Dawn Christine
/
officer: President, Markets
03/19/2024
Sell
$5.05
15,861
$80K
2.00M
NASDAQ
ALHC
Alignment Health
Scavo Robert L.
/
officer: Chief Information Officer
03/15/2024
Sell
$4.89
4,852
$24K
441,721
NASDAQ
ALHC
Alignment Health
Kardes Hakan
/
officer: Chief Experience Officer
03/19/2024
Sell
$5.05
18,964
$96K
434,807
NASDAQ
ALHC
Alignment Health
Kim Hyong
/
officer: Chief Medical Officer
03/19/2024
Sell
$5.05
5,576
$28K
555,530
NASDAQ
ALHC
Alignment Health
JOYCE CHRISTOPHER J
/
officer: Chief Legal and Admin. Officer
03/19/2024
Sell
$5.05
25,060
$127K
438,912
NASDAQ
ALHC
Alignment Health
Kardes Hakan
/
officer: Chief Experience Officer
03/15/2024
Sell
$4.89
4,326
$21K
453,771
NASDAQ
ALHC
Alignment Health
Scavo Robert L.
/
officer: Chief Information Officer
03/19/2024
Sell
$5.05
3,078
$16K
438,643
NASDAQ
ALHC
Alignment Health
Freeman Robert Thomas
/
officer: Chief Financial Officer
03/15/2024
Sell
$4.89
11,858
$58K
898,228
NASDAQ
ATEC
Alphatec
Bakst Evan
/
director
03/14/2024
Buy
$13.53
15,000
$203K
15,000
NASDAQ
FOLD
Amicus Therapeutics
Crowley John F
/
director, officer: Executive Chairman
01/10/2024
Sell
$13.65
31,614
$431K
927,013
NASDAQ
ANAB
AnaptysBio
Faga Daniel
/
director, officer: CEO
03/22/2024
Sell
$22.78
145,940
$3.325M
752,087
NASDAQ
ANAB
AnaptysBio
Faga Daniel
/
director, officer: CEO
03/25/2024
Sell
$21.42
3,000
$64K
749,087
NASDAQ
ANIX
Anixa Biosciences
Baskies Arnold M
/
director
03/15/2024
Buy
$3.63
10,000
$36K
110,000
NASDAQ
ANIX
Anixa Biosciences
KUMAR AMIT
/
officer: Chief Executive Officer
03/15/2024
Buy
$3.22
30,000
$97K
491,925
NASDAQ
APLS
Apellis Pharmaceuticals
Dunlop A. Sinclair
/
director
03/19/2024
Sell
$57.18
18,681
$1.068M
173,998
NASDAQ
APLS
Apellis Pharmaceuticals
Chopas James George
/
officer: VP/Chief Accounting Officer
03/15/2024
Sell
$56.46
184
$10K
38,883
NASDAQ
APLT
Applied Therapeutics
Shendelman Shoshana
/
director, 10 percent owner, officer: President and CEO
03/14/2024
Sell
$5.39
318,573
$1.717M
3.82M
NASDAQ
APLT
Applied Therapeutics
Funtleyder Leslie D.
/
director, officer: Chief Financial Officer
03/14/2024
Sell
$5.39
28,727
$155K
308,421
NASDAQ
APLT
Applied Therapeutics
Hansard Adam
/
officer: Chief Commercial Officer
03/14/2024
Sell
$5.39
48,871
$263K
732,919
NASDAQ
APLT
Applied Therapeutics
Perfetti Riccardo
/
officer: Chief Medical Officer
03/14/2024
Sell
$5.39
110,804
$597K
1.03M
NASDAQ
APRE
Aprea Therapeutics
HENNEMAN JOHN B III
/
director
03/13/2024
Buy
$7.29
6,860
$50K
8,139
NASDAQ
APRE
Aprea Therapeutics
Seizinger Bernd R.
/
director
03/13/2024
Buy
$7.29
6,860
$50K
33,685
NASDAQ
APRE
Aprea Therapeutics
Hamill John P.
/
officer: SrVP/CFO/Prin Fin & Acct Ofcr
03/13/2024
Buy
$7.29
1,010
$7K
15,503
NASDAQ
APRE
Aprea Therapeutics
Gilad Oren
/
director, officer: President, CEO
03/13/2024
Buy
$7.29
2,000
$15K
324,770
NASDAQ
AQST
Aquestive Therapeutics
Schobel Alexander Mark
/
officer: Chief Innovation/Tech Officer
03/15/2024
Sell
$6.00
50,000
$300K
984,476
NASDAQ
ACLX
Arcellx
Gilson Michelle
/
officer: CHIEF FINANCIAL OFFICER
03/18/2024
Sell
$69.03
3,782
$261K
12,528
NASDAQ
ACLX
Arcellx
Heery Christopher
/
officer: CHIEF MEDICAL OFFICER
03/22/2024
Sell
$71.36
4,333
$309K
9,938
NASDAQ
ACLX
Arcellx
Ware Olivia C
/
director
03/15/2024
Sell
$70.36
3,763
$265K
3,337
NASDAQ
ACLX
Arcellx
Heery Christopher
/
officer: CHIEF MEDICAL OFFICER
03/26/2024
Sell
$68.55
2,555
$175K
11,833
NASDAQ
ACLX
Arcellx
Heery Christopher
/
officer: CHIEF MEDICAL OFFICER
03/22/2024
Sell
$70.13
25,975
$1.822M
14,271
NASDAQ
ACLX
Arcellx
Ware Olivia C
/
director
03/15/2024
Sell
$69.44
1,900
$132K
7,100
NASDAQ
ACLX
Arcellx
Carroll Jill
/
director
03/21/2024
Sell
$70.55
504,263
$35.576M
1.48M
NASDAQ
ACLX
Arcellx
Heery Christopher
/
officer: CHIEF MEDICAL OFFICER
03/26/2024
Sell
$70.19
861
$60K
8,938
NASDAQ
ACLX
Arcellx
Heery Christopher
/
officer: CHIEF MEDICAL OFFICER
03/22/2024
Sell
$69.59
10,057
$700K
40,246
NASDAQ
ACLX
Arcellx
Heery Christopher
/
officer: CHIEF MEDICAL OFFICER
03/22/2024
Sell
$72.25
1,000
$72K
8,938
NASDAQ
ACLX
Arcellx
Gilson Michelle
/
officer: CHIEF FINANCIAL OFFICER
03/18/2024
Sell
$69.73
3,043
$212K
9,485
NASDAQ
ACLX
Arcellx
Heery Christopher
/
officer: CHIEF MEDICAL OFFICER
03/26/2024
Sell
$69.36
2,034
$141K
9,799
NASDAQ
ACLX
Arcellx
Ware Olivia C
/
director
03/15/2024
Sell
$70.99
3,337
$237K
0
NASDAQ
ARCT
Arcturus Therapeutics
Chivukula Pad
/
officer: Chief Scientific Officer & COO
03/19/2024
Sell
$35.01
8,565
$300K
490,883
NASDAQ
ARCT
Arcturus Therapeutics
Chivukula Pad
/
officer: Chief Scientific Officer & COO
03/25/2024
Sell
$35.02
17,435
$611K
473,448
NYSE
RCUS
Arcus Biosciences
Jarrett Jennifer
/
officer: Chief Operating Officer
03/18/2024
Sell
$18.62
1,296
$24K
226,804
NYSE
RCUS
Arcus Biosciences
Jarrett Jennifer
/
officer: Chief Operating Officer
03/18/2024
Sell
$17.84
12,153
$217K
228,100
NASDAQ
ARDX
Ardelyx
GRAMMER ELIZABETH A
/
officer: See Remarks
03/20/2024
Sell
$7.73
86,000
$665K
312,993
NASDAQ
ARWR
Arrowhead Pharmaceuticals
Lu Hongbo
/
director
03/18/2024
Buy
$27.49
1,000
$27K
31,680
NASDAQ
ARWR
Arrowhead Pharmaceuticals
Lu Hongbo
/
director
03/19/2024
Buy
$28.00
1,000
$28K
32,680
NASDAQ
ARWR
Arrowhead Pharmaceuticals
Lu Hongbo
/
director
03/20/2024
Buy
$27.50
1,000
$28K
33,680
NASDAQ
SPRY
ARS Pharmaceuticals
RA CAPITAL MANAGEMENT, L.P.
/
director, 10 percent owner:
03/26/2024
Buy
$9.55
457,745
$4.371M
9.45M
NASDAQ
SPRY
ARS Pharmaceuticals
Tanimoto Sarina
/
10 percent owner, officer: CHIEF MEDICAL OFFICER
03/25/2024
Sell
$9.12
47,632
$435K
1.95M
NASDAQ
SPRY
ARS Pharmaceuticals
Lowenthal Richard E
/
director, 10 percent owner, officer: PRESIDENT AND CEO
03/13/2024
Sell
$9.00
1,300
$12K
2.05M
NASDAQ
SPRY
ARS Pharmaceuticals
Lowenthal Richard E
/
director, 10 percent owner, officer: PRESIDENT AND CEO
03/19/2024
Sell
$9.04
942
$9K
2.00M
NASDAQ
SPRY
ARS Pharmaceuticals
Tanimoto Sarina
/
10 percent owner, officer: CHIEF MEDICAL OFFICER
03/14/2024
Sell
$9.00
239
$2K
2.05M
NASDAQ
SPRY
ARS Pharmaceuticals
Lowenthal Richard E
/
director, 10 percent owner, officer: PRESIDENT AND CEO
03/15/2024
Sell
$9.14
48,295
$441K
1.70M
NASDAQ
SPRY
ARS Pharmaceuticals
Tanimoto Sarina
/
10 percent owner, officer: CHIEF MEDICAL OFFICER
03/21/2024
Sell
$9.00
100
$900
2.00M
NASDAQ
SPRY
ARS Pharmaceuticals
RA CAPITAL MANAGEMENT, L.P.
/
director, 10 percent owner:
03/27/2024
Buy
$9.79
505,954
$4.953M
9.96M
NASDAQ
SPRY
ARS Pharmaceuticals
Tanimoto Sarina
/
10 percent owner, officer: CHIEF MEDICAL OFFICER
03/22/2024
Sell
$9.01
1,326
$12K
2.00M
NASDAQ
SPRY
ARS Pharmaceuticals
Tanimoto Sarina
/
10 percent owner, officer: CHIEF MEDICAL OFFICER
03/13/2024
Sell
$9.00
1,300
$12K
2.05M
NASDAQ
SPRY
ARS Pharmaceuticals
Lowenthal Richard E
/
director, 10 percent owner, officer: PRESIDENT AND CEO
03/14/2024
Sell
$9.00
205
$2K
1.74M
NASDAQ
SPRY
ARS Pharmaceuticals
Tanimoto Sarina
/
10 percent owner, officer: CHIEF MEDICAL OFFICER
03/15/2024
Sell
$9.14
48,295
$441K
1.70M
NASDAQ
SPRY
ARS Pharmaceuticals
Tanimoto Sarina
/
10 percent owner, officer: CHIEF MEDICAL OFFICER
03/19/2024
Sell
$9.04
942
$9K
2.00M
NASDAQ
SPRY
ARS Pharmaceuticals
Lowenthal Richard E
/
director, 10 percent owner, officer: PRESIDENT AND CEO
03/25/2024
Sell
$9.12
47,635
$435K
1.70M
NASDAQ
SPRY
ARS Pharmaceuticals
Lowenthal Richard E
/
director, 10 percent owner, officer: PRESIDENT AND CEO
03/13/2024
Sell
$9.00
1,500
$14K
1.74M
NASDAQ
SPRY
ARS Pharmaceuticals
Lowenthal Richard E
/
director, 10 percent owner, officer: PRESIDENT AND CEO
03/21/2024
Sell
$9.00
372
$3K
1.75M
NASDAQ
SPRY
ARS Pharmaceuticals
Tanimoto Sarina
/
10 percent owner, officer: CHIEF MEDICAL OFFICER
03/14/2024
Sell
$9.00
205
$2K
1.74M
NASDAQ
SPRY
ARS Pharmaceuticals
Lowenthal Richard E
/
director, 10 percent owner, officer: PRESIDENT AND CEO
03/22/2024
Sell
$9.03
1,017
$9K
1.75M
NASDAQ
SPRY
ARS Pharmaceuticals
Lowenthal Richard E
/
director, 10 percent owner, officer: PRESIDENT AND CEO
03/15/2024
Sell
$9.14
48,461
$443K
2.00M
NASDAQ
SPRY
ARS Pharmaceuticals
Tanimoto Sarina
/
10 percent owner, officer: CHIEF MEDICAL OFFICER
03/25/2024
Sell
$9.12
47,635
$435K
1.70M
NASDAQ
SPRY
ARS Pharmaceuticals
Lowenthal Richard E
/
director, 10 percent owner, officer: PRESIDENT AND CEO
03/19/2024
Sell
$9.03
976
$9K
1.75M
NASDAQ
SPRY
ARS Pharmaceuticals
Tanimoto Sarina
/
10 percent owner, officer: CHIEF MEDICAL OFFICER
03/13/2024
Sell
$9.00
1,500
$14K
1.74M
NASDAQ
SPRY
ARS Pharmaceuticals
Tanimoto Sarina
/
10 percent owner, officer: CHIEF MEDICAL OFFICER
03/21/2024
Sell
$9.00
372
$3K
1.75M
NASDAQ
SPRY
ARS Pharmaceuticals
Lowenthal Richard E
/
director, 10 percent owner, officer: PRESIDENT AND CEO
03/25/2024
Sell
$9.12
47,632
$435K
1.95M
NASDAQ
SPRY
ARS Pharmaceuticals
Lowenthal Richard E
/
director, 10 percent owner, officer: PRESIDENT AND CEO
03/14/2024
Sell
$9.00
239
$2K
2.05M
NASDAQ
SPRY
ARS Pharmaceuticals
RA CAPITAL MANAGEMENT, L.P.
/
director, 10 percent owner:
03/25/2024
Buy
$9.06
437,600
$3.965M
8.99M
NASDAQ
SPRY
ARS Pharmaceuticals
Tanimoto Sarina
/
10 percent owner, officer: CHIEF MEDICAL OFFICER
03/22/2024
Sell
$9.03
1,017
$9K
1.75M
NASDAQ
SPRY
ARS Pharmaceuticals
Lowenthal Richard E
/
director, 10 percent owner, officer: PRESIDENT AND CEO
03/21/2024
Sell
$9.00
100
$900
2.00M
NASDAQ
SPRY
ARS Pharmaceuticals
Tanimoto Sarina
/
10 percent owner, officer: CHIEF MEDICAL OFFICER
03/15/2024
Sell
$9.14
48,461
$443K
2.00M
NASDAQ
SPRY
ARS Pharmaceuticals
Tanimoto Sarina
/
10 percent owner, officer: CHIEF MEDICAL OFFICER
03/19/2024
Sell
$9.03
976
$9K
1.75M
NASDAQ
SPRY
ARS Pharmaceuticals
Lowenthal Richard E
/
director, 10 percent owner, officer: PRESIDENT AND CEO
03/22/2024
Sell
$9.01
1,326
$12K
2.00M
NYSE
AORT
Artivion
Stanton Marshall S.
/
officer: SVP, Clinical & MD Affair
02/26/2024
Sell
$20.27
1,576
$32K
72,513
NYSE
AORT
Artivion
GREEN ANDREW M
/
officer: VP Regulatory
02/27/2024
Sell
$19.83
421
$8K
44,159
NYSE
AORT
Artivion
GREEN ANDREW M
/
officer: VP Regulatory
02/26/2024
Sell
$20.27
1,199
$24K
44,580
NYSE
AORT
Artivion
Holloway Jean F
/
officer: SVP, General Counsel
02/27/2024
Sell
$19.83
485
$10K
166,367
NYSE
AORT
Artivion
Stanton Marshall S.
/
officer: SVP, Clinical & MD Affair
02/26/2024
Sell
$20.27
1,431
$29K
81,726
NYSE
AORT
Artivion
Maney Rochelle L.
/
officer: VP, Quality
02/27/2024
Sell
$19.83
370
$7K
44,148
NYSE
AORT
Artivion
Holloway Jean F
/
officer: SVP, General Counsel
02/26/2024
Sell
$20.27
1,295
$26K
155,559
NYSE
AORT
Artivion
Mackin James P
/
officer: President & CEO
02/26/2024
Sell
$20.27
17,868
$362K
650,573
NYSE
AORT
Artivion
Stanton Marshall S.
/
officer: SVP, Clinical & MD Affair
02/27/2024
Sell
$19.83
465
$9K
81,261
NYSE
AORT
Artivion
Horton Amy
/
officer: VP, Chief Accounting Officer
02/26/2024
Sell
$20.27
1,168
$24K
132,436
NYSE
AORT
Artivion
GREEN ANDREW M
/
officer: VP Regulatory
03/15/2024
Sell
$20.00
1,462
$29K
41,121
NYSE
AORT
Artivion
Holloway Jean F
/
officer: SVP, General Counsel
02/26/2024
Sell
$20.27
1,543
$31K
166,852
NYSE
AORT
Artivion
Mackin James P
/
officer: President & CEO
02/26/2024
Sell
$20.27
12,968
$263K
696,253
NYSE
AORT
Artivion
GREEN ANDREW M
/
officer: VP Regulatory
03/14/2024
Sell
$20.00
3,994
$80K
42,583
NYSE
AORT
Artivion
Davis John E
/
officer: Chief Commercial Officer
02/26/2024
Sell
$20.27
1,586
$32K
151,711
NYSE
AORT
Artivion
Horton Amy
/
officer: VP, Chief Accounting Officer
02/26/2024
Sell
$20.27
966
$20K
137,888
NYSE
AORT
Artivion
Maney Rochelle L.
/
officer: VP, Quality
02/26/2024
Sell
$20.27
1,168
$24K
39,214
NYSE
AORT
Artivion
Davis John E
/
officer: Chief Commercial Officer
02/27/2024
Sell
$19.83
584
$12K
161,988
NYSE
AORT
Artivion
Davis John E
/
officer: Chief Commercial Officer
02/26/2024
Sell
$20.27
1,875
$38K
162,572
NYSE
AORT
Artivion
Maney Rochelle L.
/
officer: VP, Quality
02/26/2024
Sell
$20.27
1,114
$23K
44,518
NYSE
AORT
Artivion
GREEN ANDREW M
/
officer: VP Regulatory
02/26/2024
Sell
$20.27
1,168
$24K
38,865
NYSE
AORT
Artivion
Getz Matthew A
/
officer: VP, Human Resources
03/12/2024
Sell
$19.94
5,000
$100K
43,536
NYSE
AORT
Artivion
Horton Amy
/
officer: VP, Chief Accounting Officer
02/27/2024
Sell
$19.83
325
$6K
137,563
NYSE
AORT
Artivion
Stanton Marshall S.
/
officer: SVP, Clinical & MD Affair
03/20/2024
Sell
$20.39
2,183
$45K
83,296
NYSE
AORT
Artivion
Horton Amy
/
officer: VP, Chief Accounting Officer
03/05/2024
Sell
$18.72
1,152
$22K
139,989
NASDAQ
ASRT
Assertio
Tyree James L
/
director
03/14/2024
Sell
$1.12
10,251
$11K
188,251
NASDAQ
ATRC
AtriCure
Dahlquist Karl S.
/
officer: Chief Legal Officer
03/18/2024
Sell
$32.16
1,885
$61K
50,954
TSX.V
ASG
Aurora Spine
BURKE EDMUND J
/
other: Trustee
03/26/2024
Buy
$5.45
3,500
$19K
6,300
TSX.V
ASG
Aurora Spine
HALEY MARK T
/
officer: President
03/20/2024
Buy
$5.40
1,000
$5K
121,594
NYSE
AVNS
Avanos Medical
Greiner Michael
/
officer: SVP - Chief Financial Officer
03/14/2024
Sell
$19.13
2,231
$43K
152,750
NYSE
AVNS
Avanos Medical
Greiner Michael
/
officer: SVP - Chief Financial Officer
03/14/2024
Sell
$19.12
714
$14K
154,981
NYSE
AVNS
Avanos Medical
Greiner Michael
/
officer: SVP - Chief Financial Officer
03/14/2024
Sell
$19.11
3,800
$73K
155,695
NYSE
AVNS
Avanos Medical
Greiner Michael
/
officer: SVP - Chief Financial Officer
03/14/2024
Sell
$19.16
110
$2K
151,495
NYSE
AVNS
Avanos Medical
Greiner Michael
/
officer: SVP - Chief Financial Officer
03/14/2024
Sell
$19.15
808
$15K
151,605
NYSE
AVNS
Avanos Medical
Greiner Michael
/
officer: SVP - Chief Financial Officer
03/14/2024
Sell
$19.14
337
$6K
152,413
NASDAQ
RNA
Avidity Biosciences
LEVIN ARTHUR A
/
director
03/19/2024
Sell
$23.97
5,000
$120K
14,830
NASDAQ
RNA
Avidity Biosciences
MacLean Michael F
/
officer: Chief Financial Officer
03/13/2024
Sell
$24.52
40,000
$981K
44,093
NASDAQ
AXGN
Axogen
Donovan Michael Patrick
/
officer: VP Operations
03/21/2024
Sell
$7.68
716
$5K
37,992
NASDAQ
AXGN
Axogen
DeVinney Erick Wayne
/
officer: Chief Innovation Officer
03/21/2024
Sell
$7.68
3,141
$24K
177,474
NASDAQ
AXGN
Axogen
Donovan Michael Patrick
/
officer: VP Operations
03/21/2024
Sell
$7.68
721
$6K
40,221
NASDAQ
AXGN
Axogen
Scopelianos Angelo
/
officer: Chief R&D Officer
03/21/2024
Sell
$7.68
5,251
$40K
52,999
NASDAQ
AXGN
Axogen
Zaderej Karen L.
/
director, officer: CEO
03/21/2024
Sell
$7.68
33,028
$254K
1.12M
NASDAQ
AXGN
Axogen
Donovan Michael Patrick
/
officer: VP Operations
03/21/2024
Sell
$7.68
4,596
$35K
54,250
NASDAQ
AXGN
Axogen
Scopelianos Angelo
/
officer: Chief R&D Officer
03/21/2024
Sell
$7.68
1,020
$8K
56,104
NASDAQ
AXGN
Axogen
Zaderej Karen L.
/
director, officer: CEO
03/21/2024
Sell
$7.68
3,086
$24K
1.13M
NASDAQ
AXGN
Axogen
Scopelianos Angelo
/
officer: Chief R&D Officer
03/21/2024
Sell
$7.68
610
$5K
57,994
NASDAQ
AXGN
Axogen
Zaderej Karen L.
/
director, officer: CEO
03/21/2024
Sell
$7.68
3,166
$24K
1.14M
NASDAQ
AXGN
Axogen
DeVinney Erick Wayne
/
officer: Chief Innovation Officer
03/21/2024
Sell
$7.68
716
$5K
165,661
NASDAQ
AXGN
Axogen
DeVinney Erick Wayne
/
officer: Chief Innovation Officer
03/21/2024
Sell
$7.68
721
$6K
167,890
NASDAQ
AXSM
Axsome Therapeutics
JEFFS ROGER
/
director
03/15/2024
Sell
$71.61
2,347
$168K
120,756
NASDAQ
AXSM
Axsome Therapeutics
JEFFS ROGER
/
director
03/14/2024
Sell
$69.70
16,976
$1.183M
120,756
NYSE
BDX
Becton Dickinson
Spoerel Thomas J
/
officer: SVP,Controller&Chief Acct Off
03/14/2024
Sell
$238.29
282
$67K
2,276
NASDAQ
BLFS
BioLife Solutions
Wichterman Troy
/
officer: Chief Financial Officer
03/21/2024
Sell
$17.83
520
$9K
127,614
NYSEAMEX
PHGE
BiomX
OrbiMed Israel BioFund GP Limited Partnership
/
10 percent owner
03/15/2024
Buy
$0.23
2.16M
$500K
2.16M
NASDAQ
BVS
Bioventus
D'Adamio Anthony
/
officer: SVP & General Counsel
03/15/2024
Sell
$5.46
3,125
$17K
51,371
NASDAQ
BVS
Bioventus
CHURCH KATRINA J
/
officer: SVP & Chief Compliance Officer
03/15/2024
Sell
$5.46
1,217
$7K
14,067
NASDAQ
BPMC
Blueprint Medicines
Albers Jeffrey W.
/
director
03/20/2024
Sell
$89.12
1,367
$122K
176,050
NASDAQ
BPMC
Blueprint Medicines
Landsittel Michael
/
officer: CHIEF FINANCIAL OFFICER
03/15/2024
Sell
$87.09
4,629
$403K
51,391
NASDAQ
BPMC
Blueprint Medicines
Albers Jeffrey W.
/
director
03/20/2024
Sell
$88.60
6,285
$557K
177,417
NASDAQ
BPMC
Blueprint Medicines
Landsittel Michael
/
officer: CHIEF FINANCIAL OFFICER
03/15/2024
Sell
$88.88
912
$81K
56,020
NASDAQ
BPMC
Blueprint Medicines
Hurley Ariel
/
officer: PRINCIPAL ACCOUNTING OFFICER
03/15/2024
Sell
$87.28
2,949
$257K
14,913
NASDAQ
BPMC
Blueprint Medicines
Hurley Ariel
/
officer: PRINCIPAL ACCOUNTING OFFICER
03/15/2024
Sell
$90.00
800
$72K
17,862
NASDAQ
BPMC
Blueprint Medicines
Albers Jeffrey W.
/
director
03/20/2024
Sell
$87.26
8,440
$736K
183,702
NASDAQ
BPMC
Blueprint Medicines
Landsittel Michael
/
officer: CHIEF FINANCIAL OFFICER
03/15/2024
Sell
$88.27
1,413
$125K
56,932
NASDAQ
BPMC
Blueprint Medicines
Hurley Ariel
/
officer: PRINCIPAL ACCOUNTING OFFICER
03/15/2024
Sell
$87.28
800
$70K
17,862
NASDAQ
BPMC
Blueprint Medicines
Albers Jeffrey W.
/
director
03/20/2024
Sell
$86.46
6,251
$540K
192,142
NASDAQ
BPMC
Blueprint Medicines
Landsittel Michael
/
officer: CHIEF FINANCIAL OFFICER
03/15/2024
Sell
$87.10
2,675
$233K
58,345
NASDAQ
BPMC
Blueprint Medicines
Albers Jeffrey W.
/
director
03/20/2024
Sell
$85.22
2,730
$233K
198,393
NASDAQ
BPMC
Blueprint Medicines
Landsittel Michael
/
officer: CHIEF FINANCIAL OFFICER
03/15/2024
Sell
$88.94
2,467
$219K
47,286
NASDAQ
BPMC
Blueprint Medicines
Albers Jeffrey W.
/
director
03/07/2024
Sell
$90.69
11,033
$1.001M
165,017
NASDAQ
BPMC
Blueprint Medicines
Landsittel Michael
/
officer: CHIEF FINANCIAL OFFICER
03/15/2024
Sell
$88.08
1,638
$144K
49,753
NYSE
BFLY
Butterfly Network
Stoica Andrei G
/
officer: Chief Technology Officer
03/25/2024
Sell
$1.03
3,298
$3K
1.50M
NASDAQ
RNAC
Cartesian Therapeutics
SPRINGER TIMOTHY A
/
director, 10 percent owner:
03/14/2024
Buy
$0.54
648,372
$352K
30.52M
NASDAQ
RNAC
Cartesian Therapeutics
SPRINGER TIMOTHY A
/
director, 10 percent owner:
03/18/2024
Buy
$0.60
19,044
$11K
31.07M
NASDAQ
RNAC
Cartesian Therapeutics
SPRINGER TIMOTHY A
/
director, 10 percent owner:
03/15/2024
Buy
$0.59
537,500
$315K
31.05M
NASDAQ
CSTL
Castle Biosciences
MAETZOLD DEREK J
/
director, officer: Pres. & Chief Exec. Officer
03/20/2024
Sell
$20.27
375
$8K
10,468
NASDAQ
CSTL
Castle Biosciences
MAETZOLD DEREK J
/
director, officer: Pres. & Chief Exec. Officer
03/20/2024
Sell
$20.27
1,175
$24K
88,579
NASDAQ
CSTL
Castle Biosciences
MAETZOLD DEREK J
/
director, officer: Pres. & Chief Exec. Officer
03/21/2024
Sell
$20.70
73
$2K
69,733
NASDAQ
CSTL
Castle Biosciences
MAETZOLD DEREK J
/
director, officer: Pres. & Chief Exec. Officer
03/20/2024
Sell
$20.27
2,295
$47K
69,806
NASDAQ
CSTL
Castle Biosciences
MAETZOLD DEREK J
/
director, officer: Pres. & Chief Exec. Officer
03/21/2024
Sell
$20.70
12
$248
10,455
NASDAQ
CSTL
Castle Biosciences
MAETZOLD DEREK J
/
director, officer: Pres. & Chief Exec. Officer
03/21/2024
Sell
$20.70
37
$766
77,439
NASDAQ
CSTL
Castle Biosciences
MAETZOLD DEREK J
/
director, officer: Pres. & Chief Exec. Officer
03/21/2024
Sell
$20.70
11
$228
10,457
NASDAQ
CSTL
Castle Biosciences
MAETZOLD DEREK J
/
director, officer: Pres. & Chief Exec. Officer
03/20/2024
Sell
$20.27
1,175
$24K
77,476
NASDAQ
CSTL
Castle Biosciences
MAETZOLD DEREK J
/
director, officer: Pres. & Chief Exec. Officer
03/20/2024
Sell
$20.27
374
$8K
10,467
NASDAQ
CSTL
Castle Biosciences
MAETZOLD DEREK J
/
director, officer: Pres. & Chief Exec. Officer
03/21/2024
Sell
$20.70
37
$766
88,542
NYSE
CTLT
Catalent
Gunther Scott
/
officer: SVP, Quality & Reg. Affairs
03/15/2024
Sell
$56.20
387
$22K
29,506
NASDAQ
CNTA
Centessa Pharmaceuticals
Anderson Karen M.
/
officer: Chief People Officer
03/25/2024
Sell
$12.21
21,165
$258K
71,525
NASDAQ
CNTA
Centessa Pharmaceuticals
Anderson Karen M.
/
officer: Chief People Officer
03/25/2024
Sell
$11.66
29,995
$350K
92,690
NASDAQ
CERS
Cerus
Jensen Chrystal
/
officer: Chief Legal Officer
03/13/2024
Sell
$2.06
17,460
$36K
508,736
NASDAQ
CERS
Cerus
Greenman William Mariner
/
director, officer: President and CEO
03/14/2024
Sell
$2.02
63,611
$128K
3.18M
NASDAQ
CERS
Cerus
Moore Carol
/
officer: SVP Reg. & Quality
03/13/2024
Sell
$1.97
10,416
$21K
490,623
NASDAQ
CERS
Cerus
Greenman William Mariner
/
director, officer: President and CEO
03/13/2024
Sell
$2.06
62,315
$128K
3.24M
NASDAQ
CERS
Cerus
Benjamin Richard J
/
officer: Chief Medical Officer
03/14/2024
Sell
$1.97
17,738
$35K
459,612
NASDAQ
CERS
Cerus
Moore Carol
/
officer: SVP Reg. & Quality
03/13/2024
Sell
$2.06
10,203
$21K
501,039
NASDAQ
CERS
Cerus
Jayaraman Vivek K
/
officer: Chief Operating Officer
03/14/2024
Sell
$1.97
26,794
$53K
878,653
NASDAQ
CERS
Cerus
Benjamin Richard J
/
officer: Chief Medical Officer
03/13/2024
Sell
$2.06
17,377
$36K
477,350
NASDAQ
CERS
Cerus
Green Kevin Dennis
/
officer: Chief Financial Officer
03/14/2024
Sell
$1.97
21,497
$42K
618,750
NASDAQ
CERS
Cerus
Jayaraman Vivek K
/
officer: Chief Operating Officer
03/13/2024
Sell
$2.06
26,247
$54K
905,447
NASDAQ
CERS
Cerus
CORASH LAURENCE M
/
officer: Chief Scientific Officer
03/14/2024
Sell
$1.97
14,360
$28K
2.34M
NASDAQ
CERS
Cerus
Green Kevin Dennis
/
officer: Chief Financial Officer
03/13/2024
Sell
$2.02
21,058
$42K
640,247
NASDAQ
CERS
Cerus
Jensen Chrystal
/
officer: Chief Legal Officer
03/14/2024
Sell
$1.97
17,824
$35K
490,912
NASDAQ
CERS
Cerus
CORASH LAURENCE M
/
officer: Chief Scientific Officer
03/13/2024
Sell
$2.06
14,067
$29K
2.35M
NYSE
CHE
Chemed
Judkins Brian C
/
officer: VP and Chief Legal Officer
03/20/2024
Sell
$645.00
11,158
$7.197M
1,422
NYSE
CHE
Chemed
Witzeman Michael D
/
officer: VP & Chief Financial Officer
03/21/2024
Sell
$643.14
2,650
$1.704M
2,882
NYSE
CI
Cigna
Cordani David
/
director, officer: Chairman & CEO
03/25/2024
Sell
$355.17
31,209
$11.084M
348,054
NYSE
CI
Cigna
Cordani David
/
director, officer: Chairman & CEO
03/22/2024
Sell
$355.11
6,338
$2.251M
348,054
NYSE
CI
Cigna
Cordani David
/
director, officer: Chairman & CEO
03/21/2024
Sell
$355.02
2,293
$814K
348,054
NASDAQ
CLSD
Clearside Biomedical
Chong Ngai Hang Victor
/
officer: CHIEF MEDICAL OFFICER
03/20/2024
Buy
$1.60
30,000
$48K
30,000
NASDAQ
CLOV
Clover Health
Loengard Anna U
/
director
03/14/2024
Buy
$0.73
137,000
$100K
538,841
NASDAQ
CLOV
Clover Health
Loengard Anna U
/
director
03/14/2024
Buy
$0.73
13,625
$10K
15,125
NASDAQ
CMPS
Compass Pathways
Goldsmith George Jay
/
director, 10 percent owner:
03/13/2024
Sell
$10.80
17,203
$186K
4.06M
NASDAQ
CMPS
Compass Pathways
Malievskaia Ekaterina
/
director, 10 percent owner:
03/13/2024
Sell
$10.80
17,203
$186K
4.06M
NASDAQ
CMPS
Compass Pathways
Goldsmith George Jay
/
director, 10 percent owner:
03/12/2024
Sell
$10.58
15,740
$167K
4.08M
NASDAQ
CMPS
Compass Pathways
Malievskaia Ekaterina
/
director, 10 percent owner:
03/13/2024
Sell
$10.80
17,203
$186K
4.06M
NASDAQ
CMPS
Compass Pathways
Goldsmith George Jay
/
director, 10 percent owner:
03/12/2024
Sell
$10.58
15,740
$167K
4.08M
NASDAQ
CMPS
Compass Pathways
Malievskaia Ekaterina
/
director, 10 percent owner:
03/12/2024
Sell
$10.58
15,740
$167K
4.08M
NASDAQ
CMPS
Compass Pathways
Malievskaia Ekaterina
/
director, 10 percent owner:
03/12/2024
Sell
$10.58
15,740
$167K
4.08M
NASDAQ
CMPS
Compass Pathways
Goldsmith George Jay
/
director, 10 percent owner:
03/13/2024
Sell
$10.80
17,203
$186K
4.06M
NASDAQ
COO
Cooper Companies
Ricupati Agostino
/
officer: SVP & CAO
03/18/2024
Sell
$100.89
29,528
$2.979M
5,081
NASDAQ
CORT
Corcept Therapeutics
Maduck Sean
/
officer: See Remarks
03/18/2024
Sell
$25.00
17,219
$430K
75,222
NASDAQ
CRNX
Crinetics Pharmaceuticals
Fust Matthew K
/
director
03/20/2024
Sell
$45.50
17,500
$796K
18,536
NASDAQ
CRNX
Crinetics Pharmaceuticals
Pizzuti Dana
/
officer: Chief Med and Dev Officer
03/20/2024
Sell
$43.69
714
$31K
27,786
NASDAQ
CRNX
Crinetics Pharmaceuticals
Fust Matthew K
/
director
03/20/2024
Sell
$43.58
17,500
$763K
18,536
NASDAQ
CRNX
Crinetics Pharmaceuticals
Pizzuti Dana
/
officer: Chief Med and Dev Officer
03/20/2024
Sell
$43.28
10,000
$433K
28,500
NASDAQ
CRNX
Crinetics Pharmaceuticals
Fust Matthew K
/
director
03/20/2024
Sell
$43.57
12,500
$545K
18,536
NASDAQ
CRNX
Crinetics Pharmaceuticals
Knight Jeff E.
/
officer: Chief Operating Officer
03/22/2024
Sell
$45.39
2,359
$107K
52,580
NASDAQ
CRNX
Crinetics Pharmaceuticals
Wilson Marc
/
officer: CFO
03/19/2024
Sell
$42.91
6,942
$298K
110,630
NASDAQ
CRNX
Crinetics Pharmaceuticals
Pizzuti Dana
/
officer: Chief Med and Dev Officer
03/20/2024
Sell
$45.89
4,375
$201K
28,500
NASDAQ
CRNX
Crinetics Pharmaceuticals
Knight Jeff E.
/
officer: Chief Operating Officer
03/22/2024
Sell
$44.22
30,000
$1.327M
54,939
NASDAQ
CYT
Cyteir Therapeutics
Leonard Braden Michael
/
10 percent owner
03/18/2024
Buy
$3.01
113,777
$342K
3.48M
NASDAQ
CYT
Cyteir Therapeutics
Leonard Braden Michael
/
10 percent owner
03/20/2024
Buy
$2.95
170,589
$503K
3.65M
NASDAQ
CTKB
Cytek Biosciences
Yan Ming
/
director, officer: CHIEF TECHNOLOGY OFFICER
03/18/2024
Sell
$6.77
20,000
$135K
6.03M
NASDAQ
CTKB
Cytek Biosciences
Yan Ming
/
director, officer: CHIEF TECHNOLOGY OFFICER
03/19/2024
Sell
$6.71
20,000
$134K
6.01M
NASDAQ
CTMX
CytomX Therapeutics
ROWLAND LLOYD A
/
officer: General Counsel
03/19/2024
Sell
$2.09
5,268
$11K
117,728
NASDAQ
CTMX
CytomX Therapeutics
Ogden Christopher
/
officer: SVP, Finance and Accounting
03/19/2024
Sell
$2.09
2,971
$6K
85,686
NASDAQ
CTMX
CytomX Therapeutics
McCarthy Sean A.
/
director, officer: CEO
03/19/2024
Sell
$2.09
20,223
$42K
524,481
NASDAQ
DAWN
Day One Biopharmaceuticals
Blackman Samuel C.
/
officer: HEAD OF R&D
03/25/2024
Sell
$16.01
10,000
$160K
1.18M
CSE
DTC
Defence Therapeutics
METZ CHRISTOPHER T
/
director, officer: President & CEO
03/15/2024
Buy
$2.27
100,000
$227K
100,000
NASDAQ
DCTH
Delcath Systems
SALAMON STEVEN A J
/
director
03/19/2024
Buy
$3.72
26,882
$100K
1.12M
NASDAQ
DCTH
Delcath Systems
Aharon Gil
/
director
03/19/2024
Buy
$3.72
26,882
$100K
1.07M
NASDAQ
DCTH
Delcath Systems
Rosalind Advisors, Inc.
/
director
03/19/2024
Buy
$0.01
619,946
$6K
836,133
NASDAQ
DSGN
Design Therapeutics
Berger Heather A.
/
director
03/25/2024
Buy
$3.74
1,300
$5K
1,300
NASDAQ
DSGN
Design Therapeutics
Schmid John P.
/
director
03/22/2024
Buy
$3.62
9,156
$33K
9,156
NASDAQ
DSGN
Design Therapeutics
Schmid John P.
/
director
03/25/2024
Buy
$3.74
17,809
$67K
26,965
NASDAQ
DXCM
DexCom
Dolan Matthew Vincent
/
officer: EVP Strategy & Corp Dev
03/15/2024
Sell
$130.77
1,314
$172K
45,370
NASDAQ
DXCM
DexCom
Dolan Matthew Vincent
/
officer: EVP Strategy & Corp Dev
03/15/2024
Sell
$129.18
1,886
$244K
46,684
NASDAQ
DXCM
DexCom
Dolan Matthew Vincent
/
officer: EVP Strategy & Corp Dev
03/15/2024
Sell
$131.39
1,003
$132K
44,367
NASDAQ
DCGO
DocGo
KATZ STEVEN
/
director
03/15/2024
Buy
$3.64
13,500
$49K
69,534
NASDAQ
DCGO
DocGo
ROSENBERG NORMAN
/
officer: CFO and Treasurer
03/14/2024
Buy
$3.61
10,000
$36K
274,222
NASDAQ
EDSA
Edesa Biotech
Nijhawan Pardeep
/
director, 10 percent owner, officer: Chief Executive Officer
03/25/2024
Buy
$4.00
5,000
$20K
341,702
NASDAQ
ELTX
Elicio Therapeutics
Chudnovsky Yekaterina
/
director, 10 percent owner:
03/19/2024
Buy
$0.01
1.03M
$10K
1.03M
NASDAQ
ELVN
Enliven Therapeutics
Kintz Samuel
/
director, officer: PRESIDENT AND CEO
03/25/2024
Sell
$18.16
4,671
$85K
0
NASDAQ
ELVN
Enliven Therapeutics
Kintz Samuel
/
director, officer: PRESIDENT AND CEO
03/25/2024
Sell
$17.17
7,329
$126K
4,671
NASDAQ
ELVN
Enliven Therapeutics
Heyman Richard A.
/
director
03/19/2024
Sell
$14.50
1,270
$18K
143,470
NASDAQ
ELVN
Enliven Therapeutics
Ballal Rahul D.
/
director
03/20/2024
Sell
$19.16
13,278
$254K
22,341
NASDAQ
ENSG
Ensign
Wittekind Beverly B.
/
officer: VP and General Counsel
03/14/2024
Sell
$122.91
236
$29K
37,912
NASDAQ
ENSG
Ensign
Wittekind Beverly B.
/
officer: VP and General Counsel
03/14/2024
Sell
$121.63
9,764
$1.188M
38,148
NASDAQ
TRDA
Entrada Therapeutics
KIM PETER S
/
director
03/22/2024
Buy
$13.76
3,118
$43K
52,894
NASDAQ
TRDA
Entrada Therapeutics
KIM PETER S
/
director
03/25/2024
Buy
$13.36
3,180
$42K
56,074
NASDAQ
TRDA
Entrada Therapeutics
KIM PETER S
/
director
03/26/2024
Buy
$13.64
2,750
$38K
58,824
NASDAQ
NVNO
enVVeno Medical
Alavi Hamed
/
officer: Chief Technology Officer
03/13/2024
Sell
$6.22
8,334
$52K
0
NASDAQ
EOLS
Evolus
MOATAZEDI DAVID
/
director, officer: See Remarks
03/19/2024
Sell
$13.92
96,566
$1.345M
695,850
NASDAQ
EOLS
Evolus
Beaver Sandra
/
officer: Chief Financial Officer
03/19/2024
Sell
$13.92
5,672
$79K
154,201
NASDAQ
EOLS
Evolus
Avelar Rui
/
officer: See Remarks
03/19/2024
Sell
$13.92
27,603
$384K
372,288
NASDAQ
EXEL
Exelixis
Garber Alan M
/
director
03/21/2024
Sell
$24.01
19,205
$461K
35,703
NASDAQ
EYEN
Eyenovia
Grant Stuart M.
/
10 percent owner
03/19/2024
Buy
$1.23
50,000
$62K
5.33M
NASDAQ
FENC
Fennec Pharmaceuticals
Andrade Robert
/
officer: CHIEF FINANCIAL OFFICER
03/26/2024
Sell
$10.90
13,975
$152K
91,771
NASDAQ
FENC
Fennec Pharmaceuticals
Andrade Robert
/
officer: CHIEF FINANCIAL OFFICER
03/25/2024
Sell
$11.00
13,975
$154K
105,746
NASDAQ
FENC
Fennec Pharmaceuticals
RALLIS CHRIS A
/
director
03/26/2024
Sell
$10.97
2,114
$23K
40,920
NASDAQ
FWBI
First Wave BioPharma
Romano Sarah
/
officer: Chief Financial Officer
03/15/2024
Sell
$4.96
1,120
$6K
19,186
NASDAQ
FWBI
First Wave BioPharma
SAPIRSTEIN JAMES
/
director, officer: Chairman and CEO
03/15/2024
Sell
$4.96
1,887
$9K
37,279
OTCMKTS
FRTX
Fresh Tracks Therapeutics
Exploration Capital, LLC
/
10 percent owner
03/19/2024
Buy
$0.90
10
$9
963,852
OTCMKTS
FRTX
Fresh Tracks Therapeutics
Exploration Capital, LLC
/
10 percent owner
03/20/2024
Buy
$0.91
287
$261
964,139
NASDAQ
GTHX
G1 Therapeutics
Umstead John W. V
/
officer: Chief Financial Officer
03/18/2024
Sell
$3.02
6,547
$20K
123,896
NASDAQ
WGS
GeneDx
Saad Kareem
/
officer: CHIEF TRANSFORMATION OFFICER
03/18/2024
Sell
$10.59
2,008
$21K
29,517
NASDAQ
WGS
GeneDx
Stueland Katherine
/
director, officer: CHIEF EXECUTIVE OFFICER
03/18/2024
Sell
$10.59
8,559
$91K
66,698
NASDAQ
WGS
GeneDx
Feeley Kevin
/
officer: CHIEF FINANCIAL OFFICER
03/18/2024
Sell
$10.59
3,253
$34K
28,927
NYSE
GMED
Globus Medical
Norwalk Leslie V
/
director
03/15/2024
Sell
$51.99
10,590
$551K
17,419
NASDAQ
GOSS
Gossamer Bio
Peterson Caryn
/
officer: EVP, Regulatory Affairs
03/18/2024
Sell
$1.33
4,018
$5K
49,833
NASDAQ
GOSS
Gossamer Bio
Aranda Richard
/
officer: Chief Medical Officer
03/18/2024
Sell
$1.33
4,018
$5K
198,799
NASDAQ
GEG
Great Elm
Reese Jason W.
/
director, 10 percent owner, officer: See remarks
03/15/2024
Buy
$2.00
7,843
$16K
6.33M
NASDAQ
GEG
Great Elm
Reese Jason W.
/
director, 10 percent owner, officer: See remarks
03/14/2024
Buy
$1.98
3,254
$6K
6.32M
NASDAQ
GLSI
Greenwich LifeSciences
Patel Snehal
/
director, 10 percent owner, officer: CEO and CFO
03/22/2024
Buy
$19.98
2,500
$50K
5.35M
NASDAQ
GLSI
Greenwich LifeSciences
Patel Snehal
/
director, 10 percent owner, officer: CEO and CFO
03/20/2024
Buy
$17.68
1,500
$27K
5.35M
NASDAQ
GH
Guardant Health
Kalia Kumud
/
officer: Chief Information Officer
03/18/2024
Buy
$17.82
2,187
$39K
12,722
NASDAQ
GYRE
Gyre Therapeutics
USMAN NASSIM
/
director
03/15/2024
Sell
$17.26
20,000
$345K
1,636
NASDAQ
HRMY
Harmony Biosciences
Dierks Jeffrey
/
officer: CHIEF COMMERCIAL OFFICER
03/15/2024
Sell
$32.00
11,979
$383K
0
NASDAQ
HROW
Harrow
Opaleye Management Inc.
/
10 percent owner
03/20/2024
Buy
$9.65
50,600
$488K
3.70M
NASDAQ
HROW
Harrow
BAUM MARK L
/
director, officer: CHIEF EXECUTIVE OFFICER
03/22/2024
Buy
$11.59
9,000
$104K
2.14M
NYSE
HCA
HCA Healthcare
Wasserman Chad J
/
officer: SVP and CIO
03/18/2024
Sell
$321.97
344
$111K
2,452
NYSE
HCA
HCA Healthcare
Wasserman Chad J
/
officer: SVP and CIO
03/20/2024
Sell
$330.25
876
$289K
1,576
NASDAQ
HCAT
Health Catalyst
Llewelyn Linda
/
officer: Chief People Officer
03/15/2024
Sell
$7.80
2,005
$16K
128,231
NASDAQ
HQY
HealthEquity
Kessler Jon
/
director, officer: PRESIDENT AND CEO
03/22/2024
Sell
$79.81
33,765
$2.695M
126,635
NASDAQ
HSIC
Henry Schein
BRESLAWSKI JAMES P
/
director, officer: Vice Chairman, President
03/18/2024
Sell
$74.37
2,907
$216K
209,562
NASDAQ
HSIC
Henry Schein
Connett Bradford C
/
officer: CEO, NA Distribution Group
03/20/2024
Sell
$74.28
6,430
$478K
73,108
NASDAQ
HLVX
HilleVax
Kohli Aditya
/
director
03/18/2024
Sell
$17.66
6,000
$106K
819,776
NASDAQ
HLVX
HilleVax
Kohli Aditya
/
director
03/20/2024
Sell
$164,221.00
6,000
$985.326M
807,776
NASDAQ
HLVX
HilleVax
Kohli Aditya
/
director
03/19/2024
Sell
$17.42
6,000
$104K
813,776
NASDAQ
HOLX
Hologic
GARRETT SCOTT T
/
director
03/14/2024
Sell
$75.50
16,441
$1.241M
48,611
NASDAQ
ICUI
ICU Medical
Woolson Daniel
/
officer: VP, GM-Infusion Capital
03/15/2024
Sell
$98.27
791
$78K
13,980
NASDAQ
IGMS
IGM Biosciences
Schwarzer Fred
/
director, officer: CEO AND PRESIDENT
03/13/2024
Sell
$9.88
4,765
$47K
220,833
NASDAQ
IGMS
IGM Biosciences
Weber Steven
/
officer: PRINCIPAL ACCOUNTING OFFICER
03/14/2024
Sell
$10.17
464
$5K
26,507
NASDAQ
IGMS
IGM Biosciences
Decker Lisa Lynn
/
officer: CHIEF BUSINESS OFFICER
03/14/2024
Sell
$10.17
1,578
$16K
61,006
NASDAQ
IGMS
IGM Biosciences
Tahir Misbah
/
officer: CHIEF FINANCIAL OFFICER
03/14/2024
Sell
$10.17
2,543
$26K
90,418
NASDAQ
IGMS
IGM Biosciences
Weber Steven
/
officer: PRINCIPAL ACCOUNTING OFFICER
03/13/2024
Sell
$9.88
529
$5K
26,971
NASDAQ
IGMS
IGM Biosciences
Decker Lisa Lynn
/
officer: CHIEF BUSINESS OFFICER
03/13/2024
Sell
$9.88
1,798
$18K
62,584
NASDAQ
IGMS
IGM Biosciences
Tahir Misbah
/
officer: CHIEF FINANCIAL OFFICER
03/13/2024
Sell
$9.88
2,897
$29K
92,961
NASDAQ
IGMS
IGM Biosciences
Keyt Bruce
/
officer: CHIEF SCIENTIFIC OFFICER
03/14/2024
Sell
$10.17
1,844
$19K
171,856
NASDAQ
IGMS
IGM Biosciences
Takimoto Chris H
/
officer: CHIEF MEDICAL OFFICER
03/14/2024
Sell
$10.17
2,535
$26K
94,388
NASDAQ
IGMS
IGM Biosciences
Keyt Bruce
/
officer: CHIEF SCIENTIFIC OFFICER
03/13/2024
Sell
$9.88
2,101
$21K
173,700
NASDAQ
IGMS
IGM Biosciences
Takimoto Chris H
/
officer: CHIEF MEDICAL OFFICER
03/13/2024
Sell
$9.88
2,889
$29K
96,923
NASDAQ
IGMS
IGM Biosciences
Schwarzer Fred
/
director, officer: CEO AND PRESIDENT
03/14/2024
Sell
$10.17
4,182
$43K
216,651
NASDAQ
IMRX
Immuneering
Hall Brett Matthew
/
officer: CHIEF SCIENTIFIC OFFICER
03/20/2024
Buy
$2.86
7,000
$20K
345,896
NASDAQ
IMRX
Immuneering
Morales Mallory
/
officer: Chief Accounting Officer
03/22/2024
Buy
$2.55
393
$1,000
8,278
NASDAQ
IMRX
Immuneering
Cormorant Asset Management, LP
/
10 percent owner
03/14/2024
Sell
$5.97
11,040
$66K
3.70M
NASDAQ
IMRX
Immuneering
Brakewood Harold Eugene
/
officer: Chief Business Officer
03/22/2024
Buy
$2.57
3,900
$10K
3,900
NASDAQ
IMRX
Immuneering
Schall Thomas J.
/
director
03/22/2024
Buy
$2.55
2,900
$7K
2,900
NASDAQ
IMRX
Immuneering
Neufeld Leah R
/
officer: CHIEF PEOPLE OFFICER
03/20/2024
Buy
$2.88
3,818
$11K
10,029
NASDAQ
IMRX
Immuneering
Cormorant Asset Management, LP
/
10 percent owner
03/14/2024
Sell
$5.37
54,215
$291K
3.71M
NASDAQ
IMRX
Immuneering
Cormorant Asset Management, LP
/
10 percent owner
03/14/2024
Sell
$4.25
98,570
$418K
3.76M
NASDAQ
IMRX
Immuneering
Feinberg Peter
/
director
03/22/2024
Buy
$2.55
25,000
$64K
111,766
NASDAQ
IMRX
Immuneering
Feinberg Peter
/
director
03/18/2024
Buy
$2.31
45,024
$104K
56,790
NASDAQ
IMRX
Immuneering
BERMAN ANN E
/
director
03/18/2024
Buy
$2.13
57,965
$123K
67,465
NASDAQ
IMRX
Immuneering
Cormorant Asset Management, LP
/
10 percent owner
03/14/2024
Sell
$3.24
345,266
$1.117M
3.86M
NASDAQ
IMRX
Immuneering
Feinberg Peter
/
director
03/18/2024
Buy
$3.05
4,976
$15K
61,766
NASDAQ
IMRX
Immuneering
Feinberg Peter
/
director
03/19/2024
Buy
$2.56
25,000
$64K
86,766
NASDAQ
IMRX
Immuneering
Zeskind Benjamin J.
/
director, 10 percent owner, officer: PRESIDENT AND CEO
03/19/2024
Buy
$2.77
20,000
$55K
2.28M
NASDAQ
IMRX
Immuneering
Morales Mallory
/
officer: Chief Accounting Officer
03/21/2024
Buy
$2.72
1,107
$3K
7,885
NASDAQ
IMRX
Immuneering
Cormorant Asset Management, LP
/
10 percent owner
03/15/2024
Sell
$2.14
400,000
$856K
3.30M
NASDAQ
NARI
Inari Medical
Hoffman William
/
director
03/18/2024
Sell
$41.45
12,508
$518K
1.00M
NASDAQ
NARI
Inari Medical
Hoffman William
/
director
03/18/2024
Sell
$40.98
27,492
$1.127M
1.02M
NYSE
INSP
Inspire Medical Systems
Rondoni John
/
officer: Chief Technology Officer
03/22/2024
Sell
$195.22
500
$98K
11,270
NYSE
INSP
Inspire Medical Systems
Rondoni John
/
officer: Chief Technology Officer
03/22/2024
Sell
$194.46
3,062
$595K
11,770
NYSE
INSP
Inspire Medical Systems
Griffin Jerry C
/
director
03/18/2024
Sell
$193.53
500
$97K
10,190
NYSE
INSP
Inspire Medical Systems
Griffin Jerry C
/
director
03/18/2024
Sell
$193.53
54
$10K
10,690
NYSE
INSP
Inspire Medical Systems
Rondoni John
/
officer: Chief Technology Officer
03/22/2024
Sell
$193.70
825
$160K
14,832
NYSE
INSP
Inspire Medical Systems
Griffin Jerry C
/
director
03/25/2024
Sell
$197.81
500
$99K
10,636
NYSE
INSP
Inspire Medical Systems
Griffin Jerry C
/
director
03/25/2024
Sell
$197.81
54
$11K
11,136
NASDAQ
ISRG
Intuitive Surgical
Widman Fredrik
/
officer: VP Corporate Controller
03/15/2024
Sell
$397.07
612
$243K
110
NASDAQ
DERM
Journey Medical
Maraoui Claude
/
director, officer: President & CEO
03/22/2024
Buy
$3.48
10,000
$35K
2.16M
NASDAQ
DERM
Journey Medical
ROSENWALD LINDSAY A MD
/
director
03/25/2024
Buy
$3.04
10,000
$30K
144,245
NASDAQ
DERM
Journey Medical
ROSENWALD LINDSAY A MD
/
director
03/22/2024
Buy
$3.40
20,000
$68K
134,245
NASDAQ
DERM
Journey Medical
Smith Justin Adam
/
director
03/22/2024
Buy
$3.47
30,000
$104K
134,717
NASDAQ
KYMR
Kymera Therapeutics
Booth Bruce
/
director
03/14/2024
Sell
$41.51
154
$6K
819,151
NASDAQ
KYMR
Kymera Therapeutics
Booth Bruce
/
director
03/14/2024
Sell
$41.51
781
$32K
4.63M
NASDAQ
KYMR
Kymera Therapeutics
Booth Bruce
/
director
03/14/2024
Sell
$40.66
2,233
$91K
819,305
NASDAQ
KYMR
Kymera Therapeutics
Booth Bruce
/
director
03/14/2024
Sell
$40.66
10,846
$441K
4.63M
NASDAQ
KYMR
Kymera Therapeutics
Booth Bruce
/
director
03/14/2024
Sell
$39.73
7,292
$290K
821,538
NASDAQ
KYMR
Kymera Therapeutics
Booth Bruce
/
director
03/14/2024
Sell
$39.73
34,473
$1.370M
4.64M
NASDAQ
KYMR
Kymera Therapeutics
Booth Bruce
/
director
03/15/2024
Sell
$41.23
329
$14K
806,697
NASDAQ
KYMR
Kymera Therapeutics
Booth Bruce
/
director
03/15/2024
Sell
$41.23
1,593
$66K
4.57M
NASDAQ
KYMR
Kymera Therapeutics
Booth Bruce
/
director
03/15/2024
Sell
$40.62
10,411
$423K
807,026
NASDAQ
KYMR
Kymera Therapeutics
Booth Bruce
/
director
03/15/2024
Sell
$40.62
49,591
$2.014M
4.57M
NASDAQ
KYMR
Kymera Therapeutics
Booth Bruce
/
director
03/15/2024
Sell
$39.31
1,714
$67K
817,437
NASDAQ
KYMR
Kymera Therapeutics
Booth Bruce
/
director
03/15/2024
Sell
$39.31
8,126
$319K
4.62M
NASDAQ
LFST
LifeStance Health
Pardo Ryan
/
officer: See Remarks
03/14/2024
Sell
$6.33
39,384
$249K
817,777
NASDAQ
LFST
LifeStance Health
Mullins Kevin Michael
/
officer: Chief Development Officer
03/14/2024
Sell
$6.33
44,540
$282K
4.75M
NASDAQ
LIFW
LifeWallet
Cano Health, Inc.
/
10 percent owner
03/21/2024
Sell
$0.75
43,711
$33K
2.19M
NASDAQ
LIFW
LifeWallet
Cano Health, Inc.
/
10 percent owner
03/18/2024
Sell
$0.79
41,937
$33K
2.31M
NASDAQ
LIFW
LifeWallet
Cano Health, Inc.
/
10 percent owner
03/26/2024
Sell
$0.73
20,000
$15K
2.09M
NASDAQ
LIFW
LifeWallet
Cano Health, Inc.
/
10 percent owner
03/20/2024
Sell
$0.76
46,246
$35K
2.23M
NASDAQ
LIFW
LifeWallet
Cano Health, Inc.
/
10 percent owner
03/15/2024
Sell
$0.78
44,305
$35K
2.35M
NASDAQ
LIFW
LifeWallet
Cano Health, Inc.
/
10 percent owner
03/25/2024
Sell
$0.74
23,600
$17K
2.11M
NASDAQ
LIFW
LifeWallet
Cano Health, Inc.
/
10 percent owner
03/19/2024
Sell
$0.77
28,057
$22K
2.28M
NASDAQ
LIFW
LifeWallet
Cano Health, Inc.
/
10 percent owner
03/14/2024
Sell
$0.77
60,745
$47K
2.39M
NASDAQ
LIFW
LifeWallet
Cano Health, Inc.
/
10 percent owner
03/22/2024
Sell
$0.75
52,502
$39K
2.14M
NASDAQ
LIPO
Lipella Pharmaceuticals
Kaufman Jonathan H
/
director, 10 percent owner, officer: See remarks below.
03/18/2024
Buy
$0.79
30,000
$24K
863,849
NASDAQ
LIPO
Lipella Pharmaceuticals
Kaufman Jonathan H
/
director, 10 percent owner, officer: See remarks below.
03/19/2024
Buy
$0.87
25,000
$22K
888,849
NASDAQ
LQDA
Liquidia
Kaseta Michael
/
officer: CFO and COO
03/18/2024
Sell
$15.82
11,315
$179K
318,181
NASDAQ
LQDA
Liquidia
Schundler Russell
/
officer: General Counsel
03/18/2024
Sell
$15.82
715
$11K
496,025
NASDAQ
LQDA
Liquidia
Kaseta Michael
/
officer: CFO and COO
03/18/2024
Sell
$15.82
851
$13K
329,496
NASDAQ
LQDA
Liquidia
Adair Jason
/
officer: Chief Business Officer
03/18/2024
Sell
$15.50
76
$1K
108,640
NASDAQ
LQDA
Liquidia
Moomaw Scott
/
officer: Chief Commercial Officer
03/18/2024
Sell
$15.82
6,108
$97K
153,466
NASDAQ
LQDA
Liquidia
Adair Jason
/
officer: Chief Business Officer
03/18/2024
Sell
$15.82
4,581
$72K
108,716
NASDAQ
LQDA
Liquidia
JEFFS ROGER
/
director, officer: Chief Executive Officer
03/18/2024
Sell
$15.82
28,583
$452K
835,345
NASDAQ
LQDA
Liquidia
Saggar Rajeev
/
officer: Chief Medical Officer
03/18/2024
Sell
$15.82
5,876
$93K
214,846
NASDAQ
LQDA
Liquidia
Saggar Rajeev
/
officer: Chief Medical Officer
03/18/2024
Sell
$15.82
1,654
$26K
220,722
NASDAQ
LQDA
Liquidia
Schundler Russell
/
officer: General Counsel
03/18/2024
Sell
$15.82
7,938
$126K
488,087
NASDAQ
MDGL
Madrigal Pharmaceuticals
BAKER BROS. ADVISORS LP
/
director
03/21/2024
Buy
$0.0001
86,741
$9
212,188
NASDAQ
MDGL
Madrigal Pharmaceuticals
BAKER BROS. ADVISORS LP
/
director
03/21/2024
Buy
$0.0001
970,951
$97
2.49M
NYSEAMEX
MAIA
MAIA Biotechnology
Smith Stan
/
director
03/14/2024
Buy
$1.30
170,940
$222K
170,940
NYSEAMEX
MAIA
MAIA Biotechnology
Guerrero Ramiro
/
director
03/14/2024
Buy
$1.17
6,928
$8K
319,600
NYSEAMEX
MAIA
MAIA Biotechnology
Smith Stan
/
director
03/14/2024
Buy
$1.17
170,940
$200K
857,568
NYSEAMEX
MAIA
MAIA Biotechnology
Luput Cristian
/
director
03/14/2024
Buy
$1.30
69,282
$90K
69,282
NYSEAMEX
MAIA
MAIA Biotechnology
Luput Cristian
/
director
03/14/2024
Buy
$1.17
69,282
$81K
367,350
NYSEAMEX
MAIA
MAIA Biotechnology
Louie Ngar Yee
/
director
03/14/2024
Buy
$1.30
170,940
$222K
170,940
NYSEAMEX
MAIA
MAIA Biotechnology
Louie Ngar Yee
/
director
03/14/2024
Buy
$1.17
170,940
$200K
1.15M
NYSEAMEX
MAIA
MAIA Biotechnology
Guerrero Ramiro
/
director
03/14/2024
Buy
$1.30
6,928
$9K
6,928
TSX.V
MRVL
Marvel Biosciences
Koopmans Chris
/
officer: EVP, Chief Operations Officer
03/15/2024
Sell
$66.44
5,000
$332K
114,117
TSX.V
MRVL
Marvel Biosciences
MURPHY MATTHEW J
/
director, officer: Chair of Board, President, CEO
03/14/2024
Sell
$66.17
30,000
$1.985M
732,929
NYSE
MCK
McKesson
TYLER BRIAN S.
/
director, officer: Chief Executive Officer
03/15/2024
Sell
$524.55
3,473
$1.822M
43,445
TSX.V
MIR
MedMira
Schopfer Brian
/
officer: Chief Financial Officer
03/20/2024
Sell
$11.00
90,910
$1.000M
211,167
NASDAQ
MEDP
Medpace
Keating Ashley M.
/
director
03/14/2024
Sell
$409.87
250
$102K
250
NASDAQ
MEDP
Medpace
BURWIG SUSAN E
/
officer: Exec. VP, Operations
03/15/2024
Sell
$403.00
102
$41K
15,181
NASDAQ
MDXG
MiMedx
Hulse William Frank IV
/
officer: General Counsel and CAO
03/13/2024
Sell
$7.95
20,381
$162K
479,959
NASDAQ
MNMD
Mind Medicine
Barrow Robert
/
director, officer: Chief Executive Officer
03/25/2024
Sell
$9.50
16,519
$157K
580,202
NASDAQ
MNMD
Mind Medicine
Karlin Dan
/
officer: Chief Medical Officer
03/25/2024
Sell
$9.50
6,578
$62K
358,452
NASDAQ
MIRM
Mirum Pharmaceuticals
Radovich Peter
/
officer: PRESIDENT AND COO
03/25/2024
Sell
$25.80
4,303
$111K
29,013
NASDAQ
MIRM
Mirum Pharmaceuticals
BJERKHOLT ERIC
/
officer: CHIEF FINANCIAL OFFICER
03/27/2024
Buy
$24.80
2,000
$50K
14,000
NASDAQ
MRNA
Moderna
AFEYAN NOUBAR
/
director
03/13/2024
Sell
$110.80
3,803
$421K
2.13M
NASDAQ
MRNA
Moderna
AFEYAN NOUBAR
/
director
03/20/2024
Sell
$103.18
5,778
$596K
2.12M
NASDAQ
MRNA
Moderna
AFEYAN NOUBAR
/
director
03/13/2024
Sell
$109.50
412
$45K
2.14M
NASDAQ
MRNA
Moderna
AFEYAN NOUBAR
/
director
03/13/2024
Sell
$108.52
600
$65K
2.14M
NASDAQ
MRNA
Moderna
AFEYAN NOUBAR
/
director
03/20/2024
Sell
$102.15
7,109
$726K
2.12M
NASDAQ
MRNA
Moderna
AFEYAN NOUBAR
/
director
03/13/2024
Sell
$107.66
2,300
$248K
2.14M
NASDAQ
MRNA
Moderna
AFEYAN NOUBAR
/
director
03/20/2024
Sell
$101.05
2,113
$214K
2.13M
NASDAQ
MRNA
Moderna
AFEYAN NOUBAR
/
director
03/13/2024
Sell
$106.60
6,281
$670K
2.14M
NASDAQ
MRNA
Moderna
AFEYAN NOUBAR
/
director
03/13/2024
Sell
$112.44
200
$22K
2.13M
NASDAQ
MRNA
Moderna
AFEYAN NOUBAR
/
director
03/13/2024
Sell
$111.69
1,404
$157K
2.13M
NYSEAMEX
MYO
Myomo
KIRK THOMAS F
/
director
03/14/2024
Buy
$3.50
50,000
$175K
186,499
NASDAQ
NTRA
Natera
Chapman Steven Leonard
/
director, officer: CEO AND PRESIDENT
03/15/2024
Sell
$87.96
19,929
$1.753M
295,298
NASDAQ
NTRA
Natera
Chapman Steven Leonard
/
director, officer: CEO AND PRESIDENT
03/15/2024
Sell
$89.63
28,334
$2.540M
232,004
NASDAQ
NTRA
Natera
Chapman Steven Leonard
/
director, officer: CEO AND PRESIDENT
03/15/2024
Sell
$88.98
34,960
$3.111M
260,338
NYSE
NEUE
NeueHealth
Mikan George Lawrence III
/
director, officer: CEO & President
03/15/2024
Sell
$7.10
3,442
$24K
69,822
NYSE
NEUE
NeueHealth
Orozco Tomas
/
officer: EVP, Consumer Care
03/15/2024
Sell
$7.10
79
$561
5,914
NYSE
NEUE
NeueHealth
Craig Jeffery Michael
/
officer: GC & Corporate Secretary
03/18/2024
Sell
$7.27
260
$2K
3,426
NYSE
NEUE
NeueHealth
Mikan George Lawrence III
/
director, officer: CEO & President
03/14/2024
Sell
$7.06
2,398
$17K
73,264
NYSE
NEUE
NeueHealth
Orozco Tomas
/
officer: EVP, Consumer Care
03/14/2024
Sell
$7.06
54
$381
5,993
NYSE
NEUE
NeueHealth
Orozco Tomas
/
officer: EVP, Consumer Care
03/18/2024
Sell
$7.27
822
$6K
5,092
NYSE
NEUE
NeueHealth
Matushak Jay
/
officer: Chief Financial Officer
03/15/2024
Sell
$7.10
248
$2K
9,726
NYSE
NEUE
NeueHealth
Scherman Jeffrey J
/
officer: Chief Accounting Officer
03/15/2024
Sell
$7.10
98
$696
4,008
NYSE
NEUE
NeueHealth
Scherman Jeffrey J
/
officer: Chief Accounting Officer
03/18/2024
Sell
$7.27
568
$4K
3,440
NYSE
NEUE
NeueHealth
Matushak Jay
/
officer: Chief Financial Officer
03/14/2024
Sell
$7.06
173
$1K
9,974
NYSE
NEUE
NeueHealth
Scherman Jeffrey J
/
officer: Chief Accounting Officer
03/14/2024
Sell
$7.06
68
$480
4,106
NYSE
NEUE
NeueHealth
Craig Jeffery Michael
/
officer: GC & Corporate Secretary
03/15/2024
Sell
$7.10
151
$1K
3,686
NYSE
NEUE
NeueHealth
Mikan George Lawrence III
/
director, officer: CEO & President
03/18/2024
Sell
$7.27
4,990
$36K
64,832
NYSE
NEUE
NeueHealth
Craig Jeffery Michael
/
officer: GC & Corporate Secretary
03/14/2024
Sell
$7.06
105
$741
3,837
NYSE
NEUE
NeueHealth
Matushak Jay
/
officer: Chief Financial Officer
03/18/2024
Sell
$7.27
1,083
$8K
8,643
NASDAQ
NBIX
Neurocrine Biosciences
MORROW GEORGE J
/
director
03/14/2024
Sell
$139.42
20,000
$2.788M
0
NASDAQ
NBIX
Neurocrine Biosciences
Delaet Ingrid
/
officer: Chief Regulatory Officer
03/13/2024
Sell
$140.14
3,000
$420K
7,507
NASDAQ
NBIX
Neurocrine Biosciences
POPS RICHARD F
/
director
03/13/2024
Sell
$140.33
23,200
$3.256M
29,512
NASDAQ
NBIX
Neurocrine Biosciences
Delaet Ingrid
/
officer: Chief Regulatory Officer
03/21/2024
Sell
$145.06
5,000
$725K
7,507
NASDAQ
NBIX
Neurocrine Biosciences
BENEVICH ERIC
/
officer: Chief Commercial Officer
03/14/2024
Sell
$139.38
69,521
$9.690M
40,778
NASDAQ
NBIX
Neurocrine Biosciences
MORROW GEORGE J
/
director
03/14/2024
Sell
$139.41
20,000
$2.788M
0
NASDAQ
NAMS
NewAmsterdam Pharma
Kastelein Johannes Jacob Pieter
/
director, officer: Chief Scientific Officer
03/26/2024
Sell
$21.50
190,476
$4.095M
0
CSE
NOVA
Nova Mentis Life Science
Grasso Michael P
/
officer: See Remarks
03/25/2024
Sell
$5.89
7,409
$44K
67,579
CSE
NOVA
Nova Mentis Life Science
LANE ROBERT LAWRENCE
/
officer: See Remarks
03/25/2024
Sell
$5.89
6,710
$40K
141,529
CSE
NOVA
Nova Mentis Life Science
Nutting Meghan
/
officer: See Remarks
03/25/2024
Sell
$5.80
2,917
$17K
55,851
CSE
NOVA
Nova Mentis Life Science
Hultberg Kelsey
/
officer: See Remarks
03/25/2024
Sell
$5.75
1,086
$6K
29,034
NASDAQ
NUVL
Nuvalent
Shair Matthew
/
director
03/25/2024
Sell
$76.74
35,545
$2.728M
1.69M
NASDAQ
NUVL
Nuvalent
Conley Emily
/
director
03/15/2024
Sell
$82.32
200
$16K
1,008
NASDAQ
NUVL
Nuvalent
Shair Matthew
/
director
03/25/2024
Sell
$77.37
105
$8K
238,522
NASDAQ
NUVL
Nuvalent
Conley Emily
/
director
03/15/2024
Sell
$81.25
2,321
$189K
1,208
NASDAQ
NUVL
Nuvalent
Noci Darlene
/
officer: Chief Development Officer
03/22/2024
Sell
$78.72
600
$47K
33,300
NASDAQ
NUVL
Nuvalent
Shair Matthew
/
director
03/25/2024
Sell
$76.74
1,895
$145K
238,627
NASDAQ
NUVL
Nuvalent
Conley Emily
/
director
03/15/2024
Sell
$80.63
7,685
$620K
3,529
NASDAQ
NUVL
Nuvalent
Noci Darlene
/
officer: Chief Development Officer
03/22/2024
Sell
$77.94
6,300
$491K
33,900
NASDAQ
NUVL
Nuvalent
Shair Matthew
/
director
03/25/2024
Sell
$77.37
1,955
$151K
1.69M
NASDAQ
NUVL
Nuvalent
Conley Emily
/
director
03/15/2024
Sell
$79.81
2,127
$170K
11,214
NASDAQ
NUVL
Nuvalent
Noci Darlene
/
officer: Chief Development Officer
03/22/2024
Sell
$77.25
13,100
$1.012M
40,200
NASDAQ
NVCT
Nuvectis Pharma
BENTSUR RON
/
director, 10 percent owner, officer: Chairman & CEO
03/18/2024
Buy
$10.29
5,000
$51K
3.24M
NASDAQ
OCUP
Ocuphire Pharma
Jhaveri Nirav S.
/
officer: Chief Financial Officer
03/21/2024
Buy
$2.10
10,000
$21K
150,000
NASDAQ
OCUP
Ocuphire Pharma
SCHACHLE JOSEPH K
/
officer: Chief Operating Officer
03/21/2024
Buy
$2.05
2,000
$4K
2,000
NASDAQ
OCUP
Ocuphire Pharma
Magrath George
/
officer: Chief Executive Officer
03/18/2024
Buy
$1.96
25,000
$49K
425,000
NASDAQ
OABI
OmniAb
FOEHR MATTHEW W
/
director, officer: President and CEO
03/22/2024
Buy
$5.19
225,000
$1.168M
2.91M
NASDAQ
OPK
OPKO Health
FROST PHILLIP MD ET AL
/
director, 10 percent owner, officer: CEO & Chairman
03/18/2024
Buy
$0.87
500,000
$437K
210.97M
NASDAQ
OPTN
OptiNose
Mahmoud Ramy A
/
director, officer: Chief Executive Officer
03/18/2024
Sell
$1.88
19,198
$36K
1.33M
NASDAQ
OPTN
OptiNose
Marino Michael F III
/
officer: Chief Legal Officer & Corp Sec
03/18/2024
Sell
$1.88
15,059
$28K
602,268
NASDAQ
OPTN
OptiNose
Krick Anthony J
/
officer: Chief Accounting Officer
03/18/2024
Sell
$1.88
2,345
$4K
143,988
NASDAQ
OM
Outset Medical
Nash Marc
/
officer: SVP Operations and R&D
03/15/2024
Sell
$2.13
2,391
$5K
242,510
NASDAQ
OVID
Ovid Therapeutics
LEVIN JEREMY M
/
director, officer: CEO
03/18/2024
Buy
$2.76
18,248
$50K
3.62M
NYSE
OWLT
Owlet
Scolnick Kathryn R.
/
officer: Chief Financial Officer
03/18/2024
Sell
$4.47
276
$1K
88,494
NYSE
OWLT
Owlet
Workman Kurt
/
director, officer: Chief Executive Officer
03/18/2024
Sell
$4.47
897
$4K
207,284
NASDAQ
PHAT
Phathom Pharmaceuticals
Curran Terrie
/
director, officer: President and Chief Executive
03/22/2024
Sell
$9.11
16,851
$154K
410,784
NYSE
PHR
Phreesia
Gandhi Balaji
/
officer: Chief Financial Officer
03/25/2024
Sell
$23.21
3,504
$81K
94,030
NYSE
PHR
Phreesia
Linetsky David
/
officer: SVP, Life Sciences
03/20/2024
Sell
$23.66
30
$710
7,095
NYSE
PHR
Phreesia
Gunzburg Janet
/
officer: Principal Accounting Officer
03/20/2024
Sell
$23.66
137
$3K
38,949
NYSE
PHR
Phreesia
Roberts Evan
/
officer: Chief Operating Officer
03/21/2024
Sell
$24.46
1,000
$24K
728,570
NYSE
PHR
Phreesia
Linetsky David
/
officer: SVP, Life Sciences
03/19/2024
Sell
$23.27
402
$9K
7,125
NYSE
PHR
Phreesia
Roberts Evan
/
officer: Chief Operating Officer
03/21/2024
Sell
$23.48
24,962
$586K
729,570
NYSE
PHR
Phreesia
Linetsky David
/
officer: SVP, Life Sciences
03/18/2024
Sell
$22.22
46
$1K
7,527
NASDAQ
PRCT
PROCEPT BioRobotics
Shiblaq Hisham
/
officer: EVP, Chief Comm. Officer
03/18/2024
Sell
$48.83
244
$12K
55,860
NASDAQ
PRCT
PROCEPT BioRobotics
Zadno Reza
/
director, officer: President, CEO
03/18/2024
Sell
$48.83
5,391
$263K
241,319
NASDAQ
PRCT
PROCEPT BioRobotics
Waters Kevin
/
officer: EVP, CFO
03/18/2024
Sell
$48.83
1,024
$50K
102,149
NASDAQ
PRCT
PROCEPT BioRobotics
Nouri Alaleh
/
officer: EVP, CLO, CORP. SEC.
03/18/2024
Sell
$48.83
441
$22K
62,472
NASDAQ
PGNY
Progyny
Schlanger David J
/
director, officer: Executive Chairman
03/25/2024
Sell
$37.65
2,597
$98K
86,312
NASDAQ
PGNY
Progyny
Schlanger David J
/
director, officer: Executive Chairman
03/26/2024
Sell
$37.50
305
$11K
86,312
NASDAQ
PGNY
Progyny
Schlanger David J
/
director, officer: Executive Chairman
03/21/2024
Sell
$37.74
5,826
$220K
86,312
NASDAQ
LUNG
Pulmonx
Rose Geoffrey Beran
/
officer: CHIEF COMMERCIAL OFFICER
03/22/2024
Sell
$9.36
1,184
$11K
307,868
NASDAQ
QSI
Quantum-Si
Hawkins Jeffrey Alan
/
director, officer: President & CEO
03/14/2024
Buy
$1.76
25,000
$44K
25,000
NASDAQ
QSI
Quantum-Si
LaPointe Christian
/
officer: General Counsel & Corp. Secr.
03/15/2024
Buy
$1.74
10,000
$17K
257,693
NASDAQ
RXRX
Recursion
Marriott Tina
/
officer: President and COO
03/21/2024
Sell
$11.34
610
$7K
639,982
NASDAQ
RXRX
Recursion
Marriott Tina
/
officer: President and COO
03/21/2024
Sell
$10.70
7,390
$79K
640,592
NASDAQ
RXRX
Recursion
Borgeson Blake
/
director
03/19/2024
Sell
$10.79
20,054
$216K
7.25M
NASDAQ
RGNX
RegenXBio
Mills Kenneth T.
/
director, officer: President and CEO
03/14/2024
Sell
$21.86
15,000
$328K
408,035
NASDAQ
RPTX
Repare Therapeutics
Zinda Michael
/
officer: EVP, CHIEF SCIENTIFIC OFFICER
03/25/2024
Sell
$4.78
450
$2K
73,668
NASDAQ
RPTX
Repare Therapeutics
Koehler Maria
/
officer: EVP, CHIEF MEDICAL OFFICER
03/27/2024
Sell
$4.62
500
$2K
232,209
NASDAQ
RPTX
Repare Therapeutics
Forte Steve
/
officer: EVP, CHIEF FINANCIAL OFFICER
03/27/2024
Sell
$4.62
825
$4K
42,212
NASDAQ
RPTX
Repare Therapeutics
Koehler Maria
/
officer: EVP, CHIEF MEDICAL OFFICER
03/26/2024
Sell
$4.60
500
$2K
232,709
NASDAQ
RPTX
Repare Therapeutics
Forte Steve
/
officer: EVP, CHIEF FINANCIAL OFFICER
03/26/2024
Sell
$4.60
825
$4K
43,037
NASDAQ
RPTX
Repare Therapeutics
Koehler Maria
/
officer: EVP, CHIEF MEDICAL OFFICER
03/25/2024
Sell
$4.78
500
$2K
233,209
NASDAQ
RPTX
Repare Therapeutics
Segal Lloyd Mitchell
/
director, officer: PRESIDENT AND CEO
03/27/2024
Sell
$4.63
2,650
$12K
83,866
NASDAQ
RPTX
Repare Therapeutics
Forte Steve
/
officer: EVP, CHIEF FINANCIAL OFFICER
03/25/2024
Sell
$4.79
825
$4K
43,862
NASDAQ
RPTX
Repare Therapeutics
Zinda Michael
/
officer: EVP, CHIEF SCIENTIFIC OFFICER
03/27/2024
Sell
$4.62
450
$2K
72,768
NASDAQ
RPTX
Repare Therapeutics
Segal Lloyd Mitchell
/
director, officer: PRESIDENT AND CEO
03/26/2024
Sell
$4.64
2,650
$12K
86,516
NASDAQ
RPTX
Repare Therapeutics
Zinda Michael
/
officer: EVP, CHIEF SCIENTIFIC OFFICER
03/26/2024
Sell
$4.61
450
$2K
73,218
NASDAQ
RPTX
Repare Therapeutics
Segal Lloyd Mitchell
/
director, officer: PRESIDENT AND CEO
03/25/2024
Sell
$4.79
2,650
$13K
89,166
NYSEAMEX
RVP
Retractable Technologies
SHAW THOMAS J
/
director, 10 percent owner, officer: PRESIDENT AND CEO
03/19/2024
Buy
$1.19
2,147
$3K
14.27M
NYSEAMEX
RVP
Retractable Technologies
SHAW THOMAS J
/
director, 10 percent owner, officer: PRESIDENT AND CEO
03/26/2024
Buy
$1.18
5,096
$6K
14.28M
NYSEAMEX
RVP
Retractable Technologies
SHAW THOMAS J
/
director, 10 percent owner, officer: PRESIDENT AND CEO
03/25/2024
Buy
$1.21
3,612
$4K
14.28M
NYSEAMEX
RVP
Retractable Technologies
SHAW THOMAS J
/
director, 10 percent owner, officer: PRESIDENT AND CEO
03/14/2024
Buy
$1.22
5,000
$6K
14.27M
NASDAQ
RVNC
Revance Therapeutics
Moxie Dwight
/
officer: CLO & GC
03/18/2024
Sell
$5.04
8,125
$41K
137,815
NASDAQ
RVNC
Revance Therapeutics
Sjuts Dustin S
/
officer: President
03/18/2024
Sell
$5.04
9,211
$46K
167,550
NASDAQ
RVNC
Revance Therapeutics
Schilke Tobin
/
officer: CFO
03/18/2024
Sell
$5.04
9,361
$47K
192,666
NASDAQ
RVMD
Revolution Medicines
Cislini Jeff
/
officer: General Counsel
03/18/2024
Sell
$31.58
1,252
$40K
55,874
NASDAQ
RVMD
Revolution Medicines
Anders Jack
/
officer: Chief Financial Officer
03/18/2024
Sell
$31.58
1,261
$40K
101,959
NASDAQ
RVMD
Revolution Medicines
GOLDSMITH MARK A
/
director, officer: See Remarks
03/18/2024
Sell
$31.58
5,788
$183K
460,379
NASDAQ
RVMD
Revolution Medicines
Horn Margaret A
/
officer: Chief Operating Officer
03/18/2024
Sell
$31.58
2,914
$92K
139,553
NASDAQ
RVMD
Revolution Medicines
Kelsey Stephen Michael
/
officer: See Remarks
03/18/2024
Sell
$31.58
2,123
$67K
270,909
NASDAQ
RZLT
Rezolute
ROBERTS BRIAN KENNETH
/
officer: Chief Medical Officer
03/07/2024
Buy
$1.85
500
$925
576
NASDAQ
RZLT
Rezolute
ROBERTS BRIAN KENNETH
/
officer: Chief Medical Officer
03/14/2024
Buy
$1.88
10,000
$19K
10,000
NASDAQ
RZLT
Rezolute
Evans Daron
/
officer: CFO
03/15/2024
Buy
$1.69
20,000
$34K
20,000
NASDAQ
RYTM
Rhythm Pharmaceuticals
Smith Hunter C
/
officer: Chief Financial Officer
03/19/2024
Sell
$39.22
15,515
$608K
97,939
NASDAQ
RYTM
Rhythm Pharmaceuticals
Cramer Pamela J.
/
officer: Chief Human Resources Officer
03/19/2024
Sell
$39.22
15,515
$608K
30,005
NASDAQ
RYTM
Rhythm Pharmaceuticals
Lee Jennifer Kayden
/
officer: EVP, Head of North America
03/20/2024
Sell
$39.33
9,066
$357K
6,852
NASDAQ
RYTM
Rhythm Pharmaceuticals
Lee Jennifer Kayden
/
officer: EVP, Head of North America
03/19/2024
Sell
$39.22
15,515
$608K
25,087
NASDAQ
RYTM
Rhythm Pharmaceuticals
Lee Jennifer Kayden
/
officer: EVP, Head of North America
03/20/2024
Sell
$38.22
9,169
$350K
15,918
NASDAQ
RYTM
Rhythm Pharmaceuticals
Mazabraud Yann
/
officer: EVP, Head of International
03/19/2024
Sell
$39.22
16,000
$628K
24,495
NASDAQ
RYTM
Rhythm Pharmaceuticals
Meeker David P
/
director, officer: President and CEO
03/19/2024
Sell
$39.22
45,494
$1.784M
174,605
NASDAQ
RYTM
Rhythm Pharmaceuticals
Shulman Joseph
/
officer: Chief Technical Officer
03/19/2024
Sell
$39.22
15,515
$608K
18,265
NASDAQ
RYTM
Rhythm Pharmaceuticals
Shulman Joseph
/
officer: Chief Technical Officer
03/21/2024
Sell
$40.34
18,235
$736K
30
NASDAQ
RCKT
Rocket Pharmaceuticals
Militello John
/
officer: See Remarks
03/21/2024
Sell
$28.10
2,490
$70K
55,239
NASDAQ
RCKT
Rocket Pharmaceuticals
Makker Gotham
/
director
03/21/2024
Sell
$28.43
274,000
$7.791M
365,912
NASDAQ
SERA
Sera Prognostics
Lindgardt Zhenya
/
director, officer: Chief Executive Officer
03/26/2024
Sell
$9.37
38,899
$364K
908,104
NASDAQ
SERA
Sera Prognostics
Boniface John J.
/
officer: Chief Scientific Officer
03/26/2024
Sell
$9.55
21,438
$205K
143,524
NASDAQ
SERA
Sera Prognostics
Boniface John J.
/
officer: Chief Scientific Officer
03/25/2024
Sell
$9.10
22,163
$202K
164,962
NASDAQ
SERA
Sera Prognostics
Aerts Austin
/
officer: Chief Financial Officer
03/26/2024
Sell
$9.37
8,092
$76K
322,488
NASDAQ
SWAV
ShockWave Medical
FRANCIS LAURA
/
director
03/26/2024
Sell
$300.00
1,500
$450K
3,551
NASDAQ
SWAV
ShockWave Medical
Zacharias Isaac
/
officer: President, CCO
03/26/2024
Sell
$287.67
4,000
$1.151M
56,818
OTCMKTS
SKYE
Skye Bioscience
5AM Partners VII, LLC
/
10 percent owner
03/13/2024
Buy
$10.00
450,000
$4.500M
8.39M
NYSE
SONX
Sonendo
Bergheim Bjarne
/
director, officer: President and CEO
03/26/2024
Sell
$0.10
11,493
$1K
1.93M
NYSE
SONX
Sonendo
Chen Roy T
/
officer: Chief Talent Officer
03/26/2024
Sell
$0.10
2,625
$274
243,061
NYSE
SNDA
Sonida Senior Living
Levinson Sam
/
10 percent owner
03/22/2024
Buy
$9.50
526,316
$5.000M
2.45M
NASDAQ
SPRB
Spruce Biosciences
Novo Holdings A/S
/
10 percent owner
03/21/2024
Sell
$0.75
465,021
$351K
2.55M
NASDAQ
SPRB
Spruce Biosciences
Novo Holdings A/S
/
10 percent owner
03/14/2024
Sell
$0.89
1.91M
$1.699M
4.81M
NASDAQ
STOK
Stoke Therapeutics
Allan Jonathan
/
officer: GENERAL COUNSEL & CORP SEC
03/19/2024
Sell
$6.10
2,349
$14K
7,724
NASDAQ
STOK
Stoke Therapeutics
Nash Huw M.
/
officer: COO & CBO
03/19/2024
Sell
$6.10
4,116
$25K
11,329
NASDAQ
STOK
Stoke Therapeutics
Kaye Edward M. MD
/
director, officer: CEO
03/19/2024
Sell
$6.10
11,150
$68K
69,350
NASDAQ
STOK
Stoke Therapeutics
Ticho Barry
/
officer: CHIEF MEDICAL OFFICER
03/19/2024
Sell
$6.10
4,116
$25K
11,469
NASDAQ
STOK
Stoke Therapeutics
Tulipano Stephen J
/
officer: CFO
03/19/2024
Sell
$6.10
4,116
$25K
20,746
NASDAQ
SMMT
Summit Therapeutics
Zanganeh Mahkam
/
director, officer: Chief Executive Officer
03/27/2024
Buy
$3.72
34,321
$128K
24.92M
NASDAQ
SMMT
Summit Therapeutics
Dhingra Ankur
/
officer: Chief Financial Officer
03/26/2024
Buy
$3.75
100,000
$375K
354,958
NASDAQ
SMMT
Summit Therapeutics
Zanganeh Mahkam
/
director, officer: Chief Executive Officer
03/26/2024
Buy
$3.75
30,000
$113K
30,000
NASDAQ
SMMT
Summit Therapeutics
Zanganeh Mahkam
/
director, officer: Chief Executive Officer
03/27/2024
Buy
$3.71
20,000
$74K
50,000
NASDAQ
SMMT
Summit Therapeutics
Zanganeh Mahkam
/
director, officer: Chief Executive Officer
03/27/2024
Buy
$3.72
26,000
$97K
520,814
NASDAQ
SUPN
Supernus Pharmaceuticals
Bhatt Padmanabh P.
/
officer: Sr. VP of IP, CSO
03/21/2024
Sell
$35.31
14,491
$512K
8,570
NASDAQ
SUPN
Supernus Pharmaceuticals
Bhatt Padmanabh P.
/
officer: Sr. VP of IP, CSO
03/13/2024
Sell
$33.48
36,116
$1.209M
8,570
NASDAQ
SUPN
Supernus Pharmaceuticals
Bhatt Padmanabh P.
/
officer: Sr. VP of IP, CSO
03/13/2024
Sell
$34.10
26,250
$895K
8,570
NASDAQ
SUPN
Supernus Pharmaceuticals
Bhatt Padmanabh P.
/
officer: Sr. VP of IP, CSO
03/20/2024
Sell
$35.31
400
$14K
8,570
NASDAQ
SUPN
Supernus Pharmaceuticals
Bhatt Padmanabh P.
/
officer: Sr. VP of IP, CSO
03/19/2024
Sell
$35.31
12,364
$437K
8,570
NASDAQ
SGRY
Surgery Partners
Doherty David T
/
officer: Chief Financial Officer
03/14/2024
Sell
$28.59
721
$21K
95,719
NASDAQ
TARS
Tarsus Pharmaceuticals
Neervannan Seshadri
/
officer: Chief Operating Officer
03/18/2024
Sell
$30.60
4,879
$149K
64,767
NASDAQ
TARS
Tarsus Pharmaceuticals
Wahl Bryan
/
officer: General Counsel
03/18/2024
Sell
$30.60
4,436
$136K
40,951
NASDAQ
TARS
Tarsus Pharmaceuticals
Whitfield Dianne C.
/
officer: Chief Human Resources Officer
03/18/2024
Sell
$30.60
4,314
$132K
34,181
NASDAQ
TARS
Tarsus Pharmaceuticals
Mottiwala Aziz
/
officer: Chief Commercial Officer
03/18/2024
Sell
$30.60
4,766
$146K
54,075
NASDAQ
TARS
Tarsus Pharmaceuticals
Azamian Bobak R.
/
director, officer: President/CEO and Board Chair
03/18/2024
Sell
$30.60
10,415
$319K
26,456
NYSE
TDOC
Teladoc Health
Trencher Daniel
/
officer: CHIEF STRATEGY OFFICER
03/18/2024
Sell
$15.18
1,000
$15K
27,192
NYSE
TDOC
Teladoc Health
Geshuri Arnnon
/
officer: CHIEF PEOPLE OFFICER
03/25/2024
Sell
$15.06
7,500
$113K
38,470
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/22/2024
Sell
$238.29
3,661
$872K
130
NASDAQ
UTHR
United Therapeutics
MAHON PAUL A
/
officer: EVP & GENERAL COUNSEL
03/21/2024
Sell
$235.73
238
$56K
41,615
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/19/2024
Sell
$236.28
2,958
$699K
7,561
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/19/2024
Sell
$239.30
1,653
$396K
130
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/26/2024
Sell
$247.63
5,926
$1.467M
8,564
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/25/2024
Sell
$246.57
509
$126K
1,562
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/25/2024
Sell
$242.12
3,421
$828K
9,749
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/22/2024
Sell
$235.34
735
$173K
12,615
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/21/2024
Sell
$237.38
2,497
$593K
130
NASDAQ
UTHR
United Therapeutics
MAHON PAUL A
/
officer: EVP & GENERAL COUNSEL
03/21/2024
Sell
$234.11
857
$201K
41,853
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/20/2024
Sell
$235.19
3,642
$857K
9,198
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/20/2024
Sell
$237.21
2,863
$679K
280
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/25/2024
Sell
$244.88
502
$123K
2,071
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/25/2024
Sell
$241.05
1,492
$360K
13,170
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/22/2024
Sell
$234.62
1,780
$418K
13,350
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/26/2024
Sell
$250.64
444
$111K
130
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/21/2024
Sell
$236.57
8,650
$2.046M
2,627
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/19/2024
Sell
$235.08
2,409
$566K
10,519
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/19/2024
Sell
$238.48
2,825
$674K
1,783
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/25/2024
Sell
$243.90
2,924
$713K
2,573
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/26/2024
Sell
$246.46
496
$122K
14,490
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/21/2024
Sell
$234.38
1,353
$317K
13,777
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/22/2024
Sell
$237.56
5,212
$1.238M
3,791
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/20/2024
Sell
$234.33
2,290
$537K
12,840
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/25/2024
Sell
$248.49
603
$150K
130
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/20/2024
Sell
$236.37
6,055
$1.431M
3,143
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/19/2024
Sell
$233.98
975
$228K
12,928
NASDAQ
UTHR
United Therapeutics
MAHON PAUL A
/
officer: EVP & GENERAL COUNSEL
03/21/2024
Sell
$237.36
1,400
$332K
36,710
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/26/2024
Sell
$248.42
4,366
$1.085M
4,198
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/25/2024
Sell
$239.60
468
$112K
14,662
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/22/2024
Sell
$236.62
3,612
$855K
9,003
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/26/2024
Sell
$249.48
3,624
$904K
574
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/19/2024
Sell
$233.25
1,227
$286K
13,903
NASDAQ
UTHR
United Therapeutics
MAHON PAUL A
/
officer: EVP & GENERAL COUNSEL
03/21/2024
Sell
$236.71
3,505
$830K
38,110
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/19/2024
Sell
$237.08
2,953
$700K
4,608
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/26/2024
Sell
$244.67
144
$35K
14,986
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/20/2024
Sell
$238.28
150
$36K
130
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/25/2024
Sell
$243.09
4,252
$1.034M
5,497
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/25/2024
Sell
$247.59
829
$205K
733
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: CHAIRPERSON & CEO
03/21/2024
Sell
$235.58
2,500
$589K
11,277
NASDAQ
URGN
UroGen Pharma
Schoenberg Mark
/
officer: Chief Medical Officer
03/18/2024
Sell
$14.05
12,000
$169K
139,437
NASDAQ
VREX
Varex Imaging
Honeysett Kimberley E.
/
officer: SVP and CLO
03/15/2024
Sell
$17.37
2,860
$50K
2,853
NASDAQ
PCVX
Vaxcyte
GUGGENHIME ANDREW
/
officer: PRESIDENT AND CFO
03/18/2024
Sell
$69.64
236
$16K
95,679
NASDAQ
PCVX
Vaxcyte
PICKERING GRANT
/
director, officer: CHIEF EXECUTIVE OFFICER
03/25/2024
Sell
$67.50
1,550
$105K
477,847
NASDAQ
PCVX
Vaxcyte
PICKERING GRANT
/
director, officer: CHIEF EXECUTIVE OFFICER
03/25/2024
Sell
$66.87
13,450
$899K
479,397
NASDAQ
PCVX
Vaxcyte
GUGGENHIME ANDREW
/
officer: PRESIDENT AND CFO
03/18/2024
Sell
$69.00
7,764
$536K
95,915
NASDAQ
VERA
Vera Therapeutics
Katabi Maha
/
director
03/21/2024
Sell
$45.52
12,617
$574K
3.56M
NASDAQ
VERA
Vera Therapeutics
Katabi Maha
/
director
03/21/2024
Sell
$44.00
21,918
$964K
3.57M
NASDAQ
VERA
Vera Therapeutics
Katabi Maha
/
director
03/21/2024
Sell
$43.00
32,756
$1.409M
3.60M
NASDAQ
VERA
Vera Therapeutics
Katabi Maha
/
director
03/25/2024
Sell
$40.50
340,000
$13.770M
2.79M
NASDAQ
VERA
Vera Therapeutics
Katabi Maha
/
director
03/22/2024
Sell
$40.51
413,450
$16.749M
3.13M
NASDAQ
VERA
Vera Therapeutics
Katabi Maha
/
director
03/21/2024
Sell
$46.18
13,718
$633K
3.55M
NASDAQ
VSTM
Verastem Oncology
Gagnon Robert E.
/
director
03/18/2024
Sell
$10.71
283
$3K
27,521
NASDAQ
VSTM
Verastem Oncology
Stuglik Brian M
/
director
03/19/2024
Sell
$10.38
273
$3K
89,640
NASDAQ
VSTM
Verastem Oncology
Stuglik Brian M
/
director
03/18/2024
Sell
$10.71
537
$6K
89,913
NASDAQ
VSTM
Verastem Oncology
Paterson Dan
/
director, officer: President and CEO
03/19/2024
Sell
$10.38
182
$2K
86,490
NASDAQ
VSTM
Verastem Oncology
Paterson Dan
/
director, officer: President and CEO
03/18/2024
Sell
$10.71
244
$3K
86,672
NASDAQ
VSTM
Verastem Oncology
Gagnon Robert E.
/
director
03/19/2024
Sell
$10.38
130
$1K
27,391
NASDAQ
VSTM
Verastem Oncology
Calkins Daniel
/
officer: Chief Financial Officer
03/25/2024
Sell
$12.02
25
$301
8,541
NASDAQ
VCEL
Vericel
Colangelo Dominick
/
director, officer: President and CEO
03/14/2024
Sell
$44.02
17,500
$770K
194,870
NASDAQ
VCEL
Vericel
Colangelo Dominick
/
director, officer: President and CEO
03/13/2024
Sell
$44.67
17,500
$782K
194,870
NASDAQ
VTRS
Viatris
Mauro Anthony
/
officer: See Remarks
03/13/2024
Sell
$12.09
250,000
$3.024M
243,044
NYSE
RBOT
Vicarious Surgical
Kelly William John
/
officer: CFO and Treasurer
03/20/2024
Sell
$0.34
1,290
$437
517,841
NYSE
RBOT
Vicarious Surgical
Khalifa Sammy
/
director, 10 percent owner, officer: Chief Technology Officer
03/20/2024
Sell
$0.34
3,863
$1K
1.22M
NYSE
RBOT
Vicarious Surgical
Sachs Adam David
/
director, 10 percent owner, officer: CEO
03/20/2024
Sell
$0.34
4,830
$2K
1.73M
NASDAQ
VIR
Vir Biotechnology
Lee Sung
/
officer: EVP & Chief Financial Officer
03/27/2024
Sell
$9.89
6,008
$59K
100,492
NASDAQ
XERS
Xeris Biopharma
Schmid John P.
/
director
03/14/2024
Buy
$2.16
4,500
$10K
11,000
NASDAQ
ZLAB
Zai Lab
Edmondson Frazor Titus III
/
officer: Chief Legal Officer
03/15/2024
Sell
$18.71
10,000
$187K
20,005
NASDAQ
ZLAB
Zai Lab
Amado Rafael
/
officer: See Remarks
03/15/2024
Sell
$18.86
2,544
$48K
20,093
NYSE
ZTS
Zoetis
Lagano Roxanne
/
officer: Executive Vice President
03/18/2024
Sell
$173.33
923
$160K
15,723
Research Tools
Stock Screener
FDA Catalyst Calendar
Insider Transactions
Life Science Stock Lists
All Life Science Stocks
News & Announcements
All Life Science Stock News
Clinical Trial News
Company FDA Updates
Mergers & Acquisitions
Search News & Events
Popular Topics
Top Stocks in 2024
Big Pharma Stocks
Artificial Intelligence
Obesity Drugs
Psychedelic Stocks
Miscellaneous
Free Daily Newsletter
Follow Us On Twitter
Advertise Your Company
Privacy Policy
Disclaimer
Tweet
Share
Share
Share
Share
Sign Up To Get Daily Life Science Stock News
Register
or
Login
to Access Entire Platform.